<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biosci Microbiota Food Health</journal-id>
<journal-id journal-id-type="iso-abbrev">Biosci Microbiota Food Health</journal-id>
<journal-id journal-id-type="publisher-id">BMFH</journal-id>
<journal-title-group>
<journal-title>Bioscience of Microbiota, Food and Health</journal-title>
</journal-title-group>
<issn pub-type="ppub">2186-6953</issn>
<issn pub-type="epub">2186-3342</issn>
<publisher>
<publisher-name>BMFH Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31763115</article-id>
<article-id pub-id-type="pmc">6856517</article-id>
<article-id pub-id-type="publisher-id">19-002</article-id>
<article-id pub-id-type="doi">10.12938/bmfh.19-002</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A nutritional approach to microbiota in Parkinson’s disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>UYAR</surname>
<given-names>Gizem Özata</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>YILDIRAN</surname>
<given-names>Hilal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><label>1</label>Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Besevler, Ankara, Turkey</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">*Corresponding author. Gizem Özata Uyar (E-mail: <email xlink:href="gizemozata91@gmail.com">gizemozata91@gmail.com</email>)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>38</volume>
<issue>4</issue>
<fpage>115</fpage>
<lpage>127</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>©2019 BMFH Press</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/"> https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>)</license-p>
</license>
</permissions>
<abstract>
<p>Parkinson’s disease (PD) is a neurodegenerative disease characterized by motor impairment and the accumulation of alpha-synucleinopathy (α-syn), which can affect different levels of the
brain-gut axis. There is a two-way communication between the gastrointestinal tract, and brain that includes the gut microbiota. This bidirectional communication between the gut microbiota
and the brain includes many pathways, such as immune mechanisms, the vagus nerve, and microbial neurometabolite production. The common cause of constipation in PD is thought to be the
accumulation of α-syn proteins in the enteric nervous system. Recent studies have focused on changes in microbial metabolites and gut microbiota dysbiosis. Microbiota dysbiosis is associated
with increased intestinal permeability, intestinal inflammation, and neuroinflammation. Many factors, such as unbalanced nutrition, antibiotic use, age, and infection, result in alteration
of microbial metabolites, triggering α-syn accumulation in the intestinal mucosa cells. Increased evidence indicates that the amount, type, and balance of dietary macronutrients
(carbohydrates, proteins, and fats); high consumption of vegetables, fruits, and omega-3 fatty acids; and healthy diet patterns such as the Mediterranean diet may have a great protective
impact on PD. This review focuses on the potential benefits of prebiotics, probiotics, and synbiotics to regulate microbiota dysbiosis along with the effect of diet on the gut microbiota in
PD.</p>
</abstract>
<kwd-group>
<kwd>Parkinson’s disease</kwd>
<kwd>alpha-synuclein</kwd>
<kwd>microbiota</kwd>
<kwd>nutrition</kwd>
<kwd>probiotics</kwd>
<kwd>gut-brain axis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Parkinson’s disease (PD) is the second most common neurodegenerative disorder, and it affects 0.5–1% of the population aged 65–69 years and 1–3% of the population above 80 years of age [<xref ref-type="bibr" rid="r1">1</xref>]. It is characterized by the aggregation and accumulation of alpha-synucleinopathy (α-syn) proteins in the central nervous system (CNS) and other neural
structures. The classical motor symptoms like bradykinesia, resting tremor, rigidity, and late postural instability result from the death of dopamine-producing cells in the substantia nigra.
In addition, PD patients frequently exhibit non-motor symptoms including symptoms affecting the olfactory (relating to loss of smell), gastrointestinal, cardiovascular, and urogenital systems
[<xref ref-type="bibr" rid="r2">2</xref>]. The most common gastrointestinal system (GIS) symptoms are constipation, loss of appetite, dysphagia, drooling, and gastroesophageal reflux.
Moreover, gastrointestinal function is further exacerbated following progression of the disease [<xref ref-type="bibr" rid="r3">3</xref>, <xref ref-type="bibr" rid="r4">4</xref>]. Constipation
is the most common autonomic symptom in PD [<xref ref-type="bibr" rid="r2">2</xref>, <xref ref-type="bibr" rid="r5">5</xref>] and is reported to be seen in approximately 80% of PD patients
[<xref ref-type="bibr" rid="r5">5</xref>]. The accumulation of α-syn protein in the enteric nervous system leads to increased intestinal permeability, oxidative stress, and local
inflammation. This causes neurodegenerative changes in the enteric nervous system (ENS) and may result in prolonged intestinal permeability [<xref ref-type="bibr" rid="r6">6</xref>], and
constipation [<xref ref-type="bibr" rid="r7">7</xref>, <xref ref-type="bibr" rid="r8">8</xref>]. Lewy bodies, formed as a result of misfolding α-syn proteins, are found in CNS structures,
peripheral autonomous systems, and the ENS [<xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r10">10</xref>]. The ENS is a network of neurons in the GIS wall. It plays a
major role in bidirectional communication between GIS and CNS [<xref ref-type="bibr" rid="r11">11</xref>, <xref ref-type="bibr" rid="r12">12</xref>]. Lewy body pathology in ENS may represent
the pathohistological correlate of gastrointestinal symptoms in PD. Current hypotheses suggest that ENS might be one of the first sites where Lewy body pathology appears in PD [<xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r10">10</xref>]. Lewy bodies and α-syn proteins may appear in the gut before they appear in the brain, and these observations
reveal the hypothesis that PD starts in the gut and spreads to the brain. Increased intestinal permeability in conjunction with the presence of α-syn in the gut at early stages of the disease
may cause the spreading of the disease [<xref ref-type="bibr" rid="r13">13</xref>].</p>
<p>The role of nutrition in the development and prevention of diseases has always been remarkable. New evidence suggests that the effect of diet on brain health is not because of a diet-induced
inflammatory response but is because of the effect of the composition of the diet on the gut microbiome [<xref ref-type="bibr" rid="r14">14</xref>]. The gut microbiota is essential for human
health and the immune system. It also plays a major role in the bidirectional communication between the gut and the brain [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Recent research has shown that changes in gut microbiota can influence the physiological, behavioral, and cognitive functions
of the brain [<xref ref-type="bibr" rid="r12">12</xref>, <xref ref-type="bibr" rid="r18">18</xref>]. Gut microbiota affects brain activity via the microbiota-gut-brain axis under both
physiological and pathological disease conditions [<xref ref-type="bibr" rid="r6">6</xref>]. Combinations of specific nutrients, which include neuronal precursors and cofactors, can prevent
synaptic loss and may reduce membrane-related pathology in the CNS and ENS [<xref ref-type="bibr" rid="r19">19</xref>]. In recent studies, fecal short chain fatty acid (SCFA) concentrations
were significantly reduced in PD patients [<xref ref-type="bibr" rid="r7">7</xref>, <xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r20">20</xref>] and
<italic>Prevotellaceae</italic> were reduced in the feces of PD patients was reduced as compared with that of control [<xref ref-type="bibr" rid="r7">7</xref>]. The formation of the gut
microbiota is influenced by many dietary factors. Dietary components plays an important role in the control of gut microbial populations and, thus, in the prevention, management, and treatment
of certain diseases. Some dietary factors considered to be effective in patients with PD include vegetables, fruits, fish, protein, fat [<xref ref-type="bibr" rid="r21">21</xref>],
carbohydrates, fiber [<xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r20">20</xref>], polyphenols [<xref ref-type="bibr" rid="r22">22</xref>], the Mediterranean-type diet
[<xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r24">24</xref>], and the Western-type diet [<xref ref-type="bibr" rid="r25">25</xref>]. Therefore, this review focuses
on the effects of dietary factors on the microbiota composition of PD patients and therapeutic treatment approaches.</p>
</sec>
<sec id="s2" sec-type="other">
<title>GUT-BRAIN AXIS IN PARKINSON’S DISEASE</title>
<p>Recent research has shown that changes in intestinal microbiota can affect the physiological, behavioral, and cognitive functions of the brain [<xref ref-type="bibr" rid="r12">12</xref>,
<xref ref-type="bibr" rid="r18">18</xref>]. The gut-brain axis (GBA) is a complex bidirectional communication system between the gut and the brain mediated by hormonal, immunological, and
neural signals [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. GBA includes immune mediators such as cytokines,
production of bacterial metabolites [<xref ref-type="bibr" rid="r26">26</xref>], and signal stimulation to the brain through direct action on the vagus nerve [<xref ref-type="bibr" rid="r26">26</xref>, <xref ref-type="bibr" rid="r27">27</xref>]. This axis is also responsible for the modulation of digestive processes under physiological conditions. Dysregulation of the axis, gut
dysbiosis, and inflammation are associated with various diseases including mental disorders (anxiety and depression), Alzheimer’s, inflammatory bowel disease, and obesity [<xref ref-type="bibr" rid="r15">15</xref>, <xref ref-type="bibr" rid="r28">28</xref>,<xref ref-type="bibr" rid="r29">29</xref>,<xref ref-type="bibr" rid="r30">30</xref>]. In a study conducted on
germ-free (GF) mice, to investigate the role of intestinal microbiota and bacterial metabolites in the pathogenesis of PD, a relationship between intestinal microbiota and behavior-related
brain function was found. The microbial colonization process initiates signaling mechanisms that affect neuronal circuits involved in motor control and anxiety behavior. At the same time, GF
mice compared with specific pathogen-free (SPF) mice show elevated noradrenaline (NA), dopamine (DA), and serotonin (5-HT) turnover rates in the striatum [<xref ref-type="bibr" rid="r31">31</xref>]. Serotonin is a neurotransmitter that plays an important role in the GBA, affecting both ENS and CNS levels. The gut microbiota stimulates the synthesis of various neuroactive
molecules such as serotonin, acetylcholine, melatonine, gamma aminobutyric acid (GABA), catecholamine, and histamine [<xref ref-type="bibr" rid="r16">16</xref>, <xref ref-type="bibr" rid="r32">32</xref>]. These neurotransmitters affect the regulation and control of blood flow, as well as intestinal motility, absorption of nutrients, the gastrointestinal immune system, and
microbiota. Especially in pathological conditions like inflammatory bowel diseases and PD, these neurotransmitters can cause various gastrointestinal symptoms [<xref ref-type="bibr" rid="r33">33</xref>]. Although dysbiosis has been reported in PD, it is not yet clear whether changes in the microbiota are a trigger for PD pathology. Fecal microbiota from PD patients or controls
were transplanted into individual groups of GF recipient animals. The microbiota derived from individuals with PD promoted increased α-syn-mediated motor dysfunction [<xref ref-type="bibr" rid="r34">34</xref>]. Evidence suggests that changes in the microbiota and its metabolites may be an important risk factor for PD through the gut-brain axis. Many factors such as unbalanced
nutrition, antibiotics, age, and infection lead to changes in the gut mucosal cells which cause α-syn accumulation. The vagal nerve might provide a path for the spreading of α-syn pathology
from the ENS to the brain. The aggregated α-syn spreads towards CNS via the the vagus nerve. Eventually, the aggregated α-syn arrives at the substantia nigra. The accumulation of α-syn in the
brain has been linked to neurodegeneration, neuroinflammation, and neuronal death [<xref ref-type="bibr" rid="r35">35</xref>, <xref ref-type="bibr" rid="r36">36</xref>]. The microbiota-gut
brain axis communication pathway linking gut microbial dysbiosis with brain function in PD is shown in <xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig fig-type="figure" id="fig_001" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Microbiota-gut brain axis communication in the pathogenesis of Parkinson’s disease. Multiple factors affecting the composition of gut microbiota.</p></caption><graphic xlink:href="bmfh-38-115-g001"></graphic></fig>.</p>
</sec>
<sec id="s3" sec-type="other">
<title>INTESTINAL BACTERIAL COMPOSITION AND PARKINSON DISEASE</title>
<p>Alterations in the number as well as composition of gut microbiota and microbial metabolites are found in PD patients. Intestinal dysbiosis in PD has been reported in 12 articles from six
countries: one from Finland, Japan and Russia, two from the USA, three from China, and four from Germany.</p>
<p>Scheperjans <italic>et al.</italic> [<xref ref-type="bibr" rid="r7">7</xref>] reported that alteration in the composition of gut microbiota in PD has been reported. They compared the fecal
microbiomes of 72 PD patients and 72 control subjects by the pyrosequencing of the bacterial 16S ribosomal RNA gene. The abundance of <italic>Prevotellaceae</italic> in feces of PD patients
with postural instability and gait difficulties was reduced by 77.6% as compared with controls, and there was a higher abundance of <italic>Enterobacteriaceae</italic> was found among those
patients with postural instability along with gait difficulty phenotype compared with those with tremor-dominant PD. Keshavarzian <italic>et al.</italic> [<xref ref-type="bibr" rid="r20">20</xref>] found that members of the genus <italic>Faecalibacterium</italic> were significantly more abundant in the mucosa of controls than in PD patients. Putative “proinflammatory”
<italic>Proteobacteria</italic> of the genus <italic>Ralstonia</italic> were significantly more abundant, and anti-inflammatory SCFA producers genera <italic>Blautia</italic>,
<italic>Coprococcus</italic>, and <italic>Roseburia</italic> were significantly decreased in PD patients. One clinical study reported increased levels of <italic>Akkermansia,
Lactobacillus</italic>, <italic>Bifidobacterium,</italic> and decreased levels of <italic>Lachnospiraceae</italic> in PD patients compared with controls [<xref ref-type="bibr" rid="r13">13</xref>]. Another study found that the abundance of <italic>Lactobacillus</italic> was higher despite the fact that <italic>Clostridium coccoides, Bacteroides fragilis,</italic> and
<italic>Clostridium leptum</italic> were lower in the fecal samples of PD patients [<xref ref-type="bibr" rid="r37">37</xref>]. In a recent study, changes in the content of 9 genera and 15
species of microorganisms were revealed in PD patients decreased contents of <italic>Dorea, Bacteroides, Prevotella, Faecalibacterium, Bacteroides massiliensis, Stoquefichus massiliensis,
Bacteroides coprocola, Blautia glucerasea, Dorea longicatena, Bacteroides dorei, Bacteroides plebeius, Prevotella copri, Coprococcus eutactus, and Ruminococcus callidus</italic>, and
increased contents of <italic>Christensenella, Catabacter, Lactobacillus, Oscillospira, Bifidobacterium, Christensenella minuta, Catabacter hongkongensis, Lactobacillus mucosae, Ruminococcus
bromii,</italic> and <italic>Papillibacter cinnamivorans</italic> [<xref ref-type="bibr" rid="r38">38</xref>]. In a study conducted in southern China, the abundance of
<italic>Lachnospiraceae</italic> was decreased by 42.9% in patients with PD, whereas <italic>Bifidobacteriaceae</italic> were increased enriched in patients with PD compared with age-matched
controls [<xref ref-type="bibr" rid="r39">39</xref>]. Another study conducted in China showed that <italic>genera Clostridium</italic> IV, <italic>Aquabacterium, Holdemania, Sphingomonas,
Clostridium</italic> XVIII, <italic>Butyricicoccus</italic>, and <italic>Anaerotruncus</italic> are enriched in the feces of PD patients after adjustment according to age, gender, body mass
index (BMI), and constipation. Furthermore, genera <italic>Escherichia</italic> and <italic>Shigella</italic> are negatively associated with disease duration [<xref ref-type="bibr" rid="r40">40</xref>]. A study reported that the putative cellulose-degrading bacteria from the genera <italic>Blautia, Faecalibacterium,</italic> and <italic>Ruminococcus</italic> are significantly
decreased in PD patients compared with healthy controls. The putative pathobionts from the genera <italic>Escherichia-Shigella</italic>, <italic>Streptococcus</italic>,
<italic>Proteus,</italic> and <italic>Enterococcus</italic> were significantly increased in PD subjects [<xref ref-type="bibr" rid="r41">41</xref>].</p>
<p>In a northern German cohort study, it was shown that elevated levels of <italic>Lactobacillaceae, Barnesiellaceae,</italic> and <italic>Enterococcacea</italic> occur in fecal samples of PD
patients [<xref ref-type="bibr" rid="r42">42</xref>]. Another study showed that genera <italic>Akkermansia</italic> and <italic>Prevotella</italic> are significantly more abundant in PD
patients compared with healthy controls [<xref ref-type="bibr" rid="r43">43</xref>]. Another study found that the bacterial phylum<italic> Bacteroidetes</italic> and the bacterial family
<italic>Prevotellaceae</italic> were decreased and that <italic>Enterobacteriaceae</italic> were more abundant in fecal samples from PD patients compared with matched controls [<xref ref-type="bibr" rid="r9">9</xref>]. Bedarf <italic>et al.</italic> [<xref ref-type="bibr" rid="r44">44</xref>] compared the fecal microbiomes of 31 early-stage, L-DOPA-naïve PD patients with
those of 28 age-matched controls. They found increased numbers of <italic>Verrucomicrobiaceae (Akkermansia muciniphila)</italic> and unclassified <italic>Firmicutes</italic>, whereas
<italic>Prevotellaceae (Prevotella copri)</italic> and <italic>Erysipelotrichaceae (Eubacterium biforme)</italic> were markedly decreased in PD patients. A summary of the changes observed in
the gut microbiota in patients with PD is given in <xref ref-type="table" rid="tbl_001">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>A summary of the changes observed in the gut microbiota in patients with Parkinson’s disease (Revised from Sun and Shen [<xref ref-type="bibr" rid="r36">36</xref>])</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="1" rowspan="1">İncreased</th><th align="center" colspan="1" rowspan="1">Decreased</th><th align="center" colspan="1" rowspan="1">Country</th><th align="center" colspan="1" rowspan="1">Reference</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterobacteriaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotellaceae</italic></td><td align="center" colspan="1" rowspan="1" valign="top">Finland</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r7">7</xref>]</td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Akkermansia,</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lachnospiraceae</italic></td><td align="center" colspan="1" rowspan="1" valign="top">USA</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r13">13</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacterium</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Proteobacteria (</italic>Genus<italic> Ralstonia )</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Faecalibacterium</italic></td><td align="center" colspan="1" rowspan="1" valign="top">USA</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r20">20</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Blautia</italic>, </td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Roseburia </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium coccoides</italic></td><td align="center" colspan="1" rowspan="1" valign="top">Japan</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r37">37</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides fragilis</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium leptum</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Christensenella</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Dorea </italic></td><td align="center" colspan="1" rowspan="1" valign="top">Russia</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r38">38</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Catabacter</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotella </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillospira</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Faecalibacterium </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacterium</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides massiliensis </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Christensenella minuta</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Stoquefichus massiliensis </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Catabacter hongkongensis</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides coprocola </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillus mucosae,</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Blautia glucerasea </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcus bromii,</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Dorea longicatena</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Papillibacter cinnamivorans</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides dorei</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides plebeus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotella copri </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Coprococcus eutactus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcus callidus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacteriaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lachnospiraceae</italic></td><td align="center" colspan="1" rowspan="1" valign="top">China</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r39">39</xref>]</td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Cluster IV</td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillus </italic></td><td align="center" colspan="1" rowspan="1" valign="top">China</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r40">40</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Aquabacterium</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Sediminibacterium</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Holdemania</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Sphingomonas</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Cluster XVIII</td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Butyricicoccus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Anaerotruncus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia-Shigella</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Blautia</italic></td><td align="center" colspan="1" rowspan="1" valign="top">China</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r41">41</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Faecalibacterium </italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Proteus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterobacteriaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroidetes</italic></td><td align="center" colspan="1" rowspan="1" valign="top">Germany </td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r9">9</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacterium</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotellaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Faecalibacterium prausnitzii</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Lactobacillaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top">-</td><td align="center" colspan="1" rowspan="1" valign="top">Germany</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r42">42</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Barnesiellaceae</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcacea</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Akkermansia</italic></td><td align="left" colspan="1" rowspan="1" valign="top">-</td><td align="center" colspan="1" rowspan="1" valign="top">Germany</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r43">43</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>(Akkermansia</italic> parent taxa <italic>Verrucomicrobiaceae, Verrucomicrobiales, Verrucomicrobia)</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotella</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr><tr><td align="left" colspan="4" rowspan="1" valign="top"><hr/></td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic>Verrucomicrobiaceae (Akkermansia muciniphila)</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotellaceae (Prevotella copri)</italic></td><td align="center" colspan="1" rowspan="1" valign="top">Germany</td><td align="center" colspan="1" rowspan="1" valign="top">[<xref ref-type="bibr" rid="r44">44</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Unclassified <italic>Firmicutes</italic></td><td align="left" colspan="1" rowspan="1" valign="top"><italic>Erysipelotrichaceae (Eubacterium biforme)</italic></td><td align="left" colspan="1" rowspan="1" valign="top"></td><td align="left" colspan="1" rowspan="1" valign="top"></td></tr></tbody></table></table-wrap>. This table is revised from Sun and Shen [<xref ref-type="bibr" rid="r36">36</xref>].</p>
<p>Recent studies have suggested that <italic>Helicobacter pylori </italic> infections are associated with negative interaction with the gut microbiota. <italic>H. pylori</italic> infections
produce dramatic changes in the gastric microenvironment, simultaneously influence the gastric microbiota, and also impacts the intestinal commensal communities [<xref ref-type="bibr" rid="r45">45</xref>, <xref ref-type="bibr" rid="r46">46</xref>]. <italic>H. pylori</italic> infection was reported years ago in PD patients [<xref ref-type="bibr" rid="r40">40</xref>], and
there are also several studies suggesting that the potential relationship between <italic>H. pylori</italic> and Parkinson’s disease is controversial [<xref ref-type="bibr" rid="r9">9</xref>,
<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r41">41</xref>,<xref ref-type="bibr" rid="r42">42</xref>,<xref ref-type="bibr" rid="r43">43</xref>]. <italic>H.
pylori</italic> infection was associated with an increased risk of Parkinson’s disease. A recent retrospective study involving 2,105 <italic>H. pylori</italic> infected subjects and 9,105
matched uninfected controls found that those who were infected were 2- to 3-fold more likely to be PD patients than those who were uninfected [<xref ref-type="bibr" rid="r9">9</xref>]. In
another study, <italic>H. pylori</italic> was reported in 32% of PD patients [<xref ref-type="bibr" rid="r43">43</xref>]. Therefore, the presence of <italic>H. pylori</italic> infections
should not be ignored when evaluating the gut microbiota in PD patients.</p>
<p>A pro-inflammatory microbiota profile in the PD patient’s intestinal tract might increase gut permeability, allowing leakage of bacterial products and inflammatory mediators from the
intestines [<xref ref-type="bibr" rid="r11">11</xref>]. A dysregulated microbiota-gut-brain axis in PD might underlie gastrointestinal dysfunctions which predominantly emerge many years prior
to the PD diagnosis, corroborating the theory that the pathological process spreads from the gut to the brain [<xref ref-type="bibr" rid="r2">2</xref>, <xref ref-type="bibr" rid="r4">4</xref>]. Changes in the gut microbiota also affect GIS epithelial cells, the immune system, and the ENS (both neurons and glial cells) [<xref ref-type="bibr" rid="r47">47</xref>]. Taken
together, these results may suggest that changes in the intestinal microbiota may have a direct effect on the CNS through the GBA via chronic mild systemic inflammation [<xref ref-type="bibr" rid="r48">48</xref>]. For this reason, an adequete and balanced antioxidant-rich diet may play a potential role in preventing proinflammatory conditions.</p>
<p>Nowadays, based on the current understanding of gut microbial dysbiosis, fecal microbiota transplantation is used to regulate immunological mechanisms though the microbiota-gut-brain axis for
the treatment of autism, multiple sclerosis, and other CNS diseases [<xref ref-type="bibr" rid="r49">49</xref>]. A previous study reported that the fecal microbiota transplantation in mice
with PD reduced the activation of microglia in addition to astrocytes in the substantia nigra and reduced expression of TLR4/TNF-α signaling pathway components in the gut and the brain [<xref ref-type="bibr" rid="r50">50</xref>]. However, there are still concerns regarding safety that remain to be addressed. As far as we know, there have been no randomised controlled studies. So,
further studies on a new therapeutic approach are needed in relation to the gut microbiota and fecal microbiota transplantation.</p>
</sec>
<sec id="s4" sec-type="other">
<title>EFFECT OF DIETARY THERAPY APPROACHES ON MICROBIOTA IN PD</title>
<p>Dietary fiber, antioxidants, healthy diet patterns, prebiotics, probiotics, synbiotics, etc., may impact the gut microbiota composition, enhance intestinal epithelial integrity, and reduce
the proinflammatory response, impacting the initiation of PD. For example, antibiotics, poor diet, toxins, etc., may lead to a pathological process in the enteric cell plexus causing mucosal
inflammation, oxidative stress, and decreased mucin and SCFA, thereby initiating α-synuclein accumulation.</p>
<sec>
<title>Fiber, carbohydrates and microbiota</title>
<p>Dietary fiber means carbohydrate polymers with ten or more monomeric units according to the CODEX Alimentarius Commission [<xref ref-type="bibr" rid="r51">51</xref>]. It is categorized into
two groups: as soluble and insoluble. There are two basic types of food fiber—insoluble fiber, which does not dissolve in water and is not fermented by the gut’s bacteria, in addition to
soluble fiber, which does dissolve in water and is fermented by the colon’s microorganisms or bacteria. The polysaccharides pectin, and mucilage are examples of soluble fiber, whereas
cellulose, hemicellulose, and lignin are all insoluble forms [<xref ref-type="bibr" rid="r52">52</xref>, <xref ref-type="bibr" rid="r53">53</xref>]. SCFAs (non-digestible carbohydrates) are
produced by fermentation of intestinal microbiota bacteria in the large intestine and provide up to 10% of the daily caloric requirements in humans [<xref ref-type="bibr" rid="r54">54</xref>, <xref ref-type="bibr" rid="r55">55</xref>].</p>
<p>SCFAs may have a beneficial effect on PD as they increase the motility of the gastrointestinal tract by modulating ENS activity [<xref ref-type="bibr" rid="r9">9</xref>]. In recent studies,
it has been pointed out that there are low levels of SCFAs in the stool samples of PD patients and that the chance in SCFAs indicate a change in the intestinal microbiota composition [<xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r20">20</xref>]. Unger <italic>et al.</italic> [<xref ref-type="bibr" rid="r9">9</xref>], analyzed SCFA concentrations (using
gas chromatography) and microbiota composition (using quantitative PCR) in the fecal samples of 34 PD patients in addition to 34 age-matched controls who were analyzed. Fecal SCFA
concentrations were significantly reduced in PD patients, their levels of the the bacterial phylum <italic>Bacteroidetes</italic> and the bacterial family <italic>Prevotellaceae</italic>
were reduced, and <italic>Enterobacteriaceae</italic> were more abundant in fecal samples from PD patients compared with those of matched controls [<xref ref-type="bibr" rid="r9">9</xref>].
It should be noted that especially, <italic>Prevotellaceae</italic> has various functional role which promotes a healthy intestinal environment. This enterotype is related to higher levels
of health-promoting neuroactive short chain fatty acids and a high capacity for biosynthesis of thiamine as well as folate [<xref ref-type="bibr" rid="r7">7</xref>]. On the other hand, the
decreased abundance of the <italic>Prevotellaceae</italic> bacteria family might be related to reduced mucin synthesis and increased intestinal permeability [<xref ref-type="bibr" rid="r56">56</xref>, <xref ref-type="bibr" rid="r57">57</xref>]. Increased intestinal permeability may provoke local and systemic exposure to bacterial endotoxins, which may lead to increased α-syn
expression in the large intestine [<xref ref-type="bibr" rid="r57">57</xref>, <xref ref-type="bibr" rid="r58">58</xref>].</p>
<p>Since the reduction of beneficial bacteria leads to a decrease in the production of SCFAs [<xref ref-type="bibr" rid="r56">56</xref>], supporting adequate fiber intake in PD patients could
slow down the progression of the disease by affecting the bacterial composition positively, and possibly solve many problems including gastrointestinal dysmotility.</p>
</sec>
<sec>
<title>Dietary fatty acids (Omega-3) and microbiota</title>
<p>Fatty acids (FAs) are major components in neuronal cell membranes and synapses and are essential for maintaining their structure and function. FAs have also been found to have
anti-inflammatory, antioxidative, and neuroprotective properties. The FA composition of the cell membranes is affected by diet [<xref ref-type="bibr" rid="r59">59</xref>]. There remains much
to be learned about the effects of dietary factors on the development of PD [<xref ref-type="bibr" rid="r60">60</xref>]. Evidence from animal models suggests that dietary fatty acids,
especially docosahexaenoic acids (DHA), regulate oxidative stress in the brain [<xref ref-type="bibr" rid="r61">61</xref>, <xref ref-type="bibr" rid="r62">62</xref>]. A case-control study
has investigated the association between dietary fatty acid intake of individuals and the risk of PD in Japan. Cholesterol and arachidonic acid intake were significantly positively
associated with the risk of PD. However, intake of total fat, saturated fatty acids, monounsaturated fatty acids, n-3 polyunsaturated fatty acids, α-linolenic acid, eicosapentaenoic acid,
docosahexaenoic acid, n-6 polyunsaturated fatty acids, linoleic acid, and the ratio of n-3 to n-6 polyunsaturated fatty acid intake were not associated with PD [<xref ref-type="bibr" rid="r60">60</xref>].</p>
<p>In recent studies, identification of the relationship between omega-3 fatty acids and the human gut microbiota has provided a new insight into the composition of the microbiota [<xref ref-type="bibr" rid="r63">63</xref>,<xref ref-type="bibr" rid="r64">64</xref>,<xref ref-type="bibr" rid="r65">65</xref>]. Omega-3 (PUFAs), like DHA, have anti-inflammatory properties which
might reduce oxidative stress and therefore reduce alpha-synuclein accumulation [<xref ref-type="bibr" rid="r19">19</xref>, <xref ref-type="bibr" rid="r66">66</xref>]. Holmqvist <italic>et
al.</italic> [<xref ref-type="bibr" rid="r67">67</xref>], demonstrated in an <italic>in vivo</italic> animal model from PD patient brain lysate is taken up and transported retrogradely
over a long distance via the vagal nerves from the gut to the brain after injection into the intestinal wall in an in vivo animal model [<xref ref-type="bibr" rid="r34">34</xref>]. In
another study, colonization of α-syn-overexpressing mice with microbiota from PD patients enhanced physical impairments compared with microbiota transplants from healthy human donors. These
findings indicated that gut bacteria regulate movement disorders in mice and suggest that alterations in the human microbiome represent a risk factor for PD [<xref ref-type="bibr" rid="r34">34</xref>]. There has only been one study evaluating the effect of fish oil on the brain-gut axis in the mice with PD. When oral or intrastriatal rotenone (neurotoxin) was administered to
mice, both oral and intrastriatal rotenone induced similar PD-like motor deficits, dopaminergic cell loss, delayed intestinal transit, inflammation, and α-syn accumulation in the colon. In
addition, it was found that GIS and rotetone-induced motor dysfunctions were prevented in these mice following a uridine and DHA-containing dietary intervention. So, a the dietary
intervention may provide benefits in the prevention of motor and non-motor symptoms in PD [<xref ref-type="bibr" rid="r19">19</xref>]. Another recent study revealed that found that dietary
fat intake may modify PD risk directly or by altering the response to environmental neurotoxicants including pesticides. PUFA intake was consistently associated with lower (PD) risk, and
dietary fats modified the association of PD risk with pesticide exposure. It was concluded that a diet high in PUFAs and low in saturated fat might reduce the risk of PD [<xref ref-type="bibr" rid="r68">68</xref>]. All these results may be related to bidirectional communication between the gut and the brain for the formation of the Parkinson’s-like phenotype and
pathology. Although the relationship between dietary fatty acids and PD has not been fully clarified in the literature [<xref ref-type="bibr" rid="r59">59</xref>, <xref ref-type="bibr" rid="r60">60</xref>], it can be said that dietary interventions may help prevent both motor and non-motor symptoms in PD [<xref ref-type="bibr" rid="r19">19</xref>].</p>
</sec>
<sec>
<title>Polyphenols and microbiota</title>
<p>Dietary phenolics and polyphenols are natural compounds found in foods such as vegetables, fruit, cereals, tea, coffee, and wine [<xref ref-type="bibr" rid="r69">69</xref>]. Phenolics are
characterized by having at least one aromatic ring with one or more hydroxyl groups attached. Phenolics occurring naturally can be classified into two large groups: flavonoids and
nonflavonoids [<xref ref-type="bibr" rid="r70">70</xref>,<xref ref-type="bibr" rid="r71">71</xref>,<xref ref-type="bibr" rid="r72">72</xref>]. The rate of total polphenol absorption in the
small intestine after deconjugation reactions such as deglycosylation is relatively low (5–10%) in comparison with other macro- or micronutrients [<xref ref-type="bibr" rid="r73">73</xref>,
<xref ref-type="bibr" rid="r74">74</xref>]. The remaining 90–95% of polyphenols, which are not absorbed, produce various metabolites of physiological importance in the colon [<xref ref-type="bibr" rid="r74">74</xref>]. The interaction between the phenolic compounds as dietary components and gut microbiota has gained a lot of attention in the last few years [<xref ref-type="bibr" rid="r75">75</xref>, <xref ref-type="bibr" rid="r76">76</xref>]. Some polyphenols, such as flavan-3-ols, proanthocyanidins, and hydrolyzable tannins (ellagitannins) have
been demonstrated to exert both selective prebiotic effects and selective antimicrobial effects against pathogenic gut bacteria [<xref ref-type="bibr" rid="r77">77</xref>]. First,
polyphenols are biotransformed into their metabolites by gut microbiota, which results in the increased bioavailability of polyphenols. Second, they modulate the composition of the gut
microbial population, mostly through the inhibition of pathogenic bacteria and the stimulation of beneficial bacteria. In the latter, they may act as prebiotic metabolites and enrich the
beneficial bacteria [<xref ref-type="bibr" rid="r9">9</xref>]. Therefore, the interaction between dietary polyphenols and gut microbiota may result in an impact on the health of the human
host [<xref ref-type="bibr" rid="r78">78</xref>].</p>
<p>Polyphenols are deconjugated by bacterial glycosidases, glucuronidases, in addition to sulfatases and further fermented to a wide range of low-molecular-weight phenolic acids. Therefore,
the gut microbiota has a critical role in the bioavailability of polyphenols and has been shown to regulate the health-promoting activity through conversion into more active derivatives
[<xref ref-type="bibr" rid="r79">79</xref>]. In addition to anti-inflammatory, antioxidant, antiproliferative, antidiabetic and antimicrobial effects [<xref ref-type="bibr" rid="r80">80</xref>], polyphenols have been reported to exert their neuroprotective actions via the potential to protect neurons against injury induced by neurotoxins, via an ability to suppress
neuroinflammation and the potential to promote memory, learning, and cognitive function [<xref ref-type="bibr" rid="r81">81</xref>]. Along with all these effects, there are also important
roles in the microbiota. The bioactive components of tea rich in polyphenols have been found to inhibit the growth of pathogenic bacteria such as <italic>H. pylori,</italic> [<xref ref-type="bibr" rid="r22">22</xref>] <italic>Staphylococcus aureus</italic>, and <italic>E. coli</italic> [<xref ref-type="bibr" rid="r82">82</xref>]. It has been found that citrus
polyphenols such as hesperidin, naringenin, poncirin, and diosmetin have an inhibitory effect on the growth of <italic>H. pylori</italic> [<xref ref-type="bibr" rid="r83">83</xref>].
Queipo-Ortuño <italic>et al.</italic> [<xref ref-type="bibr" rid="r84">84</xref>] evaluated the effect of a moderate intake of red wine polyphenols on select gut microbial groups implicated
in host health benefits. They found that compared with baseline, daily consumption of red wine polyphenols for 4 weeks significantly increased the numbers of <italic>Enterococcus,
Prevotella, Bacteroides, Bifidobacterium, Bacteroides uniformis, Eggerthella lenta</italic>, and <italic>Blautia coccoides-Eubacterium rectale</italic> groups. To the best of our
knowledge, the effect of polyphenol intake on the gut microbiota of PD patients has not been examined. However, a study has reported that the influence of the bioavailability of flavonoid
metabolites may interfere with the misfolding of alpha (α)-synuclein, a process that plays a central role in Parkinson’s disease and other α-synucleinopathies. The study worked on two
experimental groups of humanized gnotobiotic mice with compositionally diverse gut bacteria were orally treated with a flavanol-rich preparation (FRP). The study demonstrated that
gnotobiotic mice with compositionally diverse human microbiotas generate unique phenolic acid profiles in the cecum after orally consuming FRP flavanols [<xref ref-type="bibr" rid="r85">85</xref>]. So, polyphenols might influence the microbiota through their effects on the high levels of <italic>H. pylori</italic> [<xref ref-type="bibr" rid="r86">86</xref>] and low
levels of <italic>Prevotella</italic> [<xref ref-type="bibr" rid="r9">9</xref>] in PD. In addition, polyphenols could be used in therapies for PD with respect to the impact of inflammation
and α-syn misfolding. Epidemiologic studies have found an inverse relationship between the consumption of high amounts of vegetables and fruits in PD [<xref ref-type="bibr" rid="r87">87</xref>, <xref ref-type="bibr" rid="r88">88</xref>]. For this reason, increasing the consumption of vegetables and fruits in the prevention of PD could have positive effects on the
intestinal microbiota composition by increasing the intake of antioxidant vitamins and polyphenols.</p>
</sec>
<sec>
<title>The Mediterranean diet and western diets</title>
<p>The Mediterranean diet (MD) is regarded as one of the healthiest eating patterns [<xref ref-type="bibr" rid="r25">25</xref>]. It is characterized by high amounts of vegetables, fruits,
grains, fish, and polyunsaturated fatty acids, and is especially based on olive oil and moderate wine consumption [<xref ref-type="bibr" rid="r25">25</xref>, <xref ref-type="bibr" rid="r89">89</xref>]. Many components of MD have positive effects on health and can lead to a reduction in the incidence of many diseases, such as cancer, obesity, metabolic syndrome,
cardiovascular diseases, neurodegenerative diseases, diabetes, and inflammatory bowel disease [<xref ref-type="bibr" rid="r90">90</xref>]. The possible biological mechanisms of MD that
prevent chronic diseases are attributed to the consumption of components such as antioxidants, polyphenols, and monounsaturated-polyunsaturated fatty acids [<xref ref-type="bibr" rid="r91">91</xref>, <xref ref-type="bibr" rid="r92">92</xref>]. MD are the main determinants of intestinal microbial diversity, and dietary components affect both the microbial population and
their metabolic activities in the early stages of life [<xref ref-type="bibr" rid="r25">25</xref>]. There are some contradictory results regarding compliance with MD in PD. In a case-control
study, there was no difference in adherence to the Mediterranean diet in patients with PD [<xref ref-type="bibr" rid="r93">93</xref>], whereas in another study, adherence to MD in patients
with PD was found to be lower than that in the control group [<xref ref-type="bibr" rid="r23">23</xref>]. In addition, little is known about the effects of diet patterns, dietary components,
and nutrients on the gut microbiota. A higher ratio of <italic>Firmicutes–Bacteroidetes</italic> was related to lower adherence to MD, and greater presence of <italic>Bacteroidetes</italic>
was associated with lower animal protein intake [<xref ref-type="bibr" rid="r24">24</xref>]. High-level consumption of plant-derived foods consistent with (MD) is associated with beneficial
microbiome-related metabolomic profiles [<xref ref-type="bibr" rid="r94">94</xref>]. <italic>Prevotella</italic> concentrations were significantly reduced in PD patients [<xref ref-type="bibr" rid="r7">7</xref>, <xref ref-type="bibr" rid="r9">9</xref>]. <italic>Prevotella</italic> is associated with plant-rich diets (high levels of complex carbohydrates and
fruit<italic>/</italic>vegetable intake<italic>)</italic> [<xref ref-type="bibr" rid="r24">24</xref>, <xref ref-type="bibr" rid="r95">95</xref>] along with fiber intake [<xref ref-type="bibr" rid="r96">96</xref>, <xref ref-type="bibr" rid="r97">97</xref>]. For this reason, the impact of a Mediterranean diet pattern on microbiota may be very important in patients
with PD.</p>
<p>The Western diet is characterized by high intake of protein (animal and processed meat products), saturated fat, refined grain, sugar, alcohol, salt, and high fructose corn syrup and low
intake of fruits and vegetables [<xref ref-type="bibr" rid="r98">98</xref>, <xref ref-type="bibr" rid="r99">99</xref>]. It promotes inflammation that arises from both structural and
behavioral changes in the resident microbiome [<xref ref-type="bibr" rid="r100">100</xref>]. The Western diet can lead to increased levels of endotoxin-producing bacteria in the intestinal
tracts of both humans and mice, resulting in metabolic endotoxemia [<xref ref-type="bibr" rid="r101">101</xref>, <xref ref-type="bibr" rid="r102">102</xref>]. Lipopolysaccharides (LPS),
commonly referred to as endotoxins, are components of the cell wall of gram-negative bacteria found in the gut microbiota [<xref ref-type="bibr" rid="r103">103</xref>]. It has been found
that the Western diet induces changes in the barrier function mechanism associated with metabolic endotoxemia in rats [<xref ref-type="bibr" rid="r104">104</xref>]. Pro-inflammatory
stimulants of Toll-like receptor-2 and Toll-like receptor-4 (pathogen-associated molecular patterns, PAMPs), are abundant in some processed foods [<xref ref-type="bibr" rid="r105">105</xref>]. Diet-induced inflammation could be mediated partly by the PAMPs produced by microbes in processed foods. PAMPs (such as LPS and other Toll like receptor stimulants) arise from
bacterial growth during the process between food preparation and heat treatment, which are likely to be extended in industrial processing compared with home cooking [<xref ref-type="bibr" rid="r100">100</xref>].</p>
<p>There are some contradictory results regarding compliance with the Western diet in PD. In an epidemiological study utilizing the Health Professionals Follow-Up Study (1986–2002) and Nurses’
Health Study (1984–2000), 49,692 men and 81,676 women free of (PD) at baseline were included, and 508 of them were diagnosed with PD after 16 years of follow up. In the study, the prudent
dietary pattern, characterized by high intake of fruit, vegetables, and fish, was inversely associated with PD risk, but the Western pattern was not [<xref ref-type="bibr" rid="r88">88</xref>]. Although there have not been any studies in the literature that have assessed the relationship between intestinal microbiota and the Western diet in PD, the effect of the
Western diet on microbiota, has been evaluated in various studies [<xref ref-type="bibr" rid="r106">106</xref>, <xref ref-type="bibr" rid="r107">107</xref>]. The gut microbiota diversity and
composition were remarkably changed in apolipoprotein E (apoE) knockout (KO) mice compared with wild-type (WT) mice, especially on a Western diet. <italic>Firmicutes</italic> and
<italic>Clostridia</italic> (from class to family) were found to be enriched in apoE KO mice on a Western diet [<xref ref-type="bibr" rid="r106">106</xref>]. The relative abundance of
Firmicutes could result in an increased amount of metabolic endotoxins such as lipopolysaccharides [<xref ref-type="bibr" rid="r108">108</xref>]. A Western diet could aggravate the
inflammatory process and endotoxin-production, so these mechanisms may explain the impact on disease onset or prognosis of PD.</p>
</sec>
</sec>
<sec id="s5" sec-type="other">
<title>COMPLEMENTARY THERAPEUTIC APPROACHES</title>
<sec>
<title>Probiotics</title>
<p>Probiotics that have essential beneficial effects on human health are defined as live microorganisms. In the early 20th century, Metchnikoff discovered “healthy bacteria”, and the interest
in probiotics in food markets has increased [<xref ref-type="bibr" rid="r109">109</xref>]. The requirements that a probiotic organism should meet are as follows: resistance to gastric
acidity, resistance to bile and pancreatic enzymes, adherence to intestinal mucosa cells, colonization capacity, remain alive for long periods during transportation and storage so they can
effectively colonize a host, production of antimicrobial substances against pathogenic bacteria, and absence of translocation [<xref ref-type="bibr" rid="r110">110</xref>]. Probiotics are
one of the treatment modalities that can be involved in the modulation of intestinal microbiota [<xref ref-type="bibr" rid="r111">111</xref>]. The most commonly used probiotic microorganisms
are lactobacilli, enterococci, bifidobacteria, and a mixture of different beneficial bacteria [<xref ref-type="bibr" rid="r112">112</xref>]. The findings of gut microbiota in constipation
are inconsistent [<xref ref-type="bibr" rid="r113">113</xref>, <xref ref-type="bibr" rid="r114">114</xref>] and currently no consensus exists. In one study, <italic>Bifidobacterium</italic>
and <italic>Lactobacillus</italic> were shown to be significantly less abundant in adult patients with constipation [<xref ref-type="bibr" rid="r113">113</xref>]. However, in a
cross-sectional pilot study, the conventional probiotic genera <italic>Lactobacillus</italic> and bifidobacteria were not decreased in the microbiomes of constipated patients, and a
significantly decreased abundance of <italic>Prevotella</italic> and increased presence of several genera of <italic>Firmicutes</italic> were observed in constipated patients compared with
controls [<xref ref-type="bibr" rid="r114">114</xref>]. In a systematic review and meta-analysis including 14 randomized controlled trials, various <italic>Lactobacillus</italic> and
<italic>Bifidobacterium</italic> strains were found to have the potential to have a positive effect on functional constipation by improving gut transit time, stool frequency, and stool
consistency [<xref ref-type="bibr" rid="r115">115</xref>]. Regarding the use of probiotics for the treatment of patients with PD, the studies to date are inadequate. Cassani <italic>et
al.</italic> [<xref ref-type="bibr" rid="r116">116</xref>] assessed the effects of milk fermented with the probiotic strain <italic>Lactobacillus casei </italic>Shirota in PD patients with
constipation according to the Rome III criteria. After probiotic intake, there was a statistically significant increase in the frequency of stool and normal consistency and significant
reduction the number of patients who felt bloating, abdominal pain, and experienced a sensations of incomplete emptying. On the other hand, probiotics play an important role in providing
normal microbial balance. It has been reported that they have a potential role in the treatment along with the prevention of anxiety and depression via the brain-gut axis [<xref ref-type="bibr" rid="r28">28</xref>]. In addition, gut microbiota can affect various neurological outcomes, such as cognition, learning, and memory [<xref ref-type="bibr" rid="r117">117</xref>]. In a double-blind, placebo-controlled clinical trial that included 40 patients with a diagnosis of major depressive disorder (MDD) based on the (DSM-IV) and whose ages ranged
between 20 and 55 year, the suplementation group received <italic>Lactobacillus acidophilus</italic> (2 × 10<sup>9</sup> CFU/g), <italic>Lactobacillus casei</italic> (2 × 10<sup>9</sup>
CFU/g), and <italic>Bifidobacterium bifidum</italic> (2 × 10<sup>9</sup> CFU/g) in a capsule for 8 weeks. Probiotic administration in patients with MDD for 8 weeks had beneficial effects on
the Beck’s Depression Inventory and some metabolic markers [<xref ref-type="bibr" rid="r118">118</xref>]. Bifidobacteria treatment also resulted in a reduced 5-hyroxyindoleacetic acid
concentration in the frontal cortex and a decrease in dihydroxyphenylacetic acid in the amygdaloid cortex. The attenuation of pro-inflammatory immune responses and the elevation of the
serotonergic precursor tryptophan by bifidobacteria treatment provides encouraging evidence in support of the proposition that this probiotic might have acquire antidepressant properties
[<xref ref-type="bibr" rid="r119">119</xref>]. The effects of probiotics on severe cognitive disorders and metabolic disorders in Alzheimer’s patients have also been investigated. In a
randomized, double-blinded, and controlled clinical trial, patients were administered either milk (control group) or a mixture of probiotics (probiotic group). The probiotic supplemented
group took 200 mL/day probiotic milk containing <italic>Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum</italic>, and <italic>Lactobacillus fermentum</italic> (2 ×
10<sup>9</sup> CFU/g for each) for 12 weeks. The Mini-Mental State Examination (MMSE) score was recorded for all subjects before and after the treatment. After 12 a week of the
intervention, the probiotic-treated patients showed a significant improvement score compared with the control group in the MMSE score [<xref ref-type="bibr" rid="r120">120</xref>]. In a
randomized, double-blind, placebo-controlled clinical trial was conducted on 50 patients with PD, participants were randomly allocated into two groups to take either 8 × 10<sup>9</sup>
CFU/day of a probiotics containing, <italic>Lactobacillus acidophilus, Bifidobacterium bifidum, L. reuteri,</italic> and <italic>Lactobacillus fermentum</italic> or a placebo (n=25 each
group, one capsule daily) for 12 weeks. Probiotic supplementation for 12 weeks in PD patients significantly downregulated gene expression of proinflammatory IL-1, IL-8, TNF-α; and
upregulated TGF-β along with peroxisome proliferator-activated receptor gamma (PPAR-γ). However, probiotic supplementation did not affect the gene expression of Vascular endothelial growth
factor (VEGF) and low-density lipoprotein receptor (LDLR) [<xref ref-type="bibr" rid="r121">121</xref>]. Another randomized, double-blind, placebo-controlled clinical trial, the impact of
probiotic supplementation (8 × 10<sup>9</sup> CFU/day probiotic or placebo) for 12 weeks on the movement and the metabolic parameters were evaluated in 60 people with PD. Compared with the
placebo, consuming the probiotics decreased the Movement Disorders Society-Unified the Parkinson’s Disease Rating Scale (MDS-UPDRS) scores; reduced high-sensitivity C-reactive protein,
malondialdehyde, and insulin levels, insulin resistance, enhanced glutathione levels, and insulin sensitivity [<xref ref-type="bibr" rid="r122">122</xref>]. Therefore, it is not possible to
give a clear recommendation for probiotic supplementation in patients with PD, due to insufficiency of the randomized controlled trials to date, lack of knowledge about the effect on
levodopa, and insufficient knowledge of the recommended dose amount, optimal duration of treatment, and reliability.</p>
</sec>
<sec>
<title>Prebiotics</title>
<p>Prebiotics are dietary substances (mostly consisting of nonstarch polysaccharides and oligosaccharides poorly digested by human enzymes) which nurture a selected group of microorganisms
living in the gut. They favor the growth of beneficial bacteria over that of harmful ones [<xref ref-type="bibr" rid="r123">123</xref>]. An ideal prebiotic should 1) be resistant to the
action of acids in the stomach, bile salts, and other hydrolyzing enzymes in the intestines, 2) not be absorbed in the upper gastrointestinal tract, 3) be easily fermentable by the
beneficial intestinal microflora [<xref ref-type="bibr" rid="r124">124</xref>, <xref ref-type="bibr" rid="r125">125</xref>]. Prebiotics are nondigestible nutrients. Short-chain nondigestible
carbohydrates, inulin-type fructans, fructooligosaccharides (FOS), and galactooligosaccharides (GOS) are the most important prebiotics. They target bacterial groups which are generally
<italic>Bifidobacterium</italic> and <italic>Lactobacillus.</italic> Fructans such as inulin and FOS are naturally present in different foods [<xref ref-type="bibr" rid="r126">126</xref>,
<xref ref-type="bibr" rid="r127">127</xref>]. Prebiotic forms a group of diverse carbohydrate ingredients. These include vegetables, fruits, cereals, and other edibles of plant origins.
Some of the sources of prebiotics include tomatoes, artichokes, bananas, asparagus, berries, garlic, onions, chicory, green vegetables, and cereals such as oats, flax seeds, and barley
[<xref ref-type="bibr" rid="r128">128</xref>].</p>
<p>Prebiotics have beneficial effects on cardiovascular diseases, type 2 diabetes/glycemic control, appetite control, obesity, cancer, immune function, and inflammation [<xref ref-type="bibr" rid="r129">129</xref>]. Inulin-like fructan consumption can also be beneficial because it stimulate intestinal movements by affecting microflora [<xref ref-type="bibr" rid="r130">130</xref>] in PD patients with constipation. Very recently, it has been demonstrated that treatment with microbial-produced SCFAs could rescue impaired microglial function impaired in GF
animals [<xref ref-type="bibr" rid="r131">131</xref>]. It has been suggested that SCFAs resulting from fermentation of dietary fiber could have epigenetic and neuromodulatory effects through
histone acetylation and improve cognitive functions for neurodevelopmental and neurodegenerative diseases [<xref ref-type="bibr" rid="r132">132</xref>]. In a study by Savignac and colleagues
[<xref ref-type="bibr" rid="r133">133</xref>], healthy rats were gavaged with FOS, GOS, or water for five weeks. After prebiotic intake, it was found that the increase of hippocampal
brain-derived neurotrophic factor (BDNF) and increased N-methyl-d-aspartate receptor (NMDAR) subunits translate to improved cognitive performance. This study demonstrates that prebiotics may
play a role in the neurological preservation of the CNS. There are no studies that have evaluated the effects of prebiotics in PD alone. However, prebiotics could be considered an effective
treatment for both constipation and gastrointestinal disturbance.</p>
</sec>
<sec>
<title>Synbiotics</title>
<p>The word ‘synbiotics’ alludes to synergism, and this term should be reserved for products in which prebiotic compound(s) selectively favors the probiotic organism(s) [<xref ref-type="bibr" rid="r134">134</xref>]. Synbiotics have both probiotic and prebiotic properties. They were also created to overcome some possible difficulties in the survival of probiotics in the
gastrointestinal tract. The principal purpose of this type of combination is the improvement of the survival of probiotic microorganisms in the gastrointestinal tract [<xref ref-type="bibr" rid="r127">127</xref>]. Polysaccharides such as inulin, reflux starch, cellulose, hemicellulose, and pectin may potentially be prebiotics. Examples of prebiotics and probiotics most
commonly used together as synbiotics are are indicated in <xref ref-type="table" rid="tbl_002">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Examples of synbiotics used in human nutrition (Adapted [<xref ref-type="bibr" rid="r128">128</xref>, <xref ref-type="bibr" rid="r135">135</xref>, <xref ref-type="bibr" rid="r136">136</xref>])</title></caption><graphic xlink:href="bmfh-38-115-t002"></graphic></table-wrap> (Adapted [<xref ref-type="bibr" rid="r128">128</xref>, <xref ref-type="bibr" rid="r135">135</xref>, <xref ref-type="bibr" rid="r136">136</xref>]). Synbiotic intake may
efficiently restore the balance of gut microbiota and improve gastrointestinal functions. A randomized, placebo-controlled trial suggested that dietary supplementation with a synbiotic (the
synbiotic [BIFICOPEC]containing 0.63 g of bifid triple viable capsules [BIFICO] and 8 g of soluble dietary fiber) improved evacuation-parameters-associated symptoms and colonic motility in
patients with slow transit constipation [<xref ref-type="bibr" rid="r137">137</xref>]. GIS-related problems in particular are of great importance for patients with PD. For example, in a
randomized, double-blind, placebo-controlled trial, on PD patients with Rome III-confirmed constipation based on 2-week stool diary data at baseline, patients were randomly assigned (80 in
the experimental group, 40 placebo group) to either fermented milk containing multiple probiotic strains and prebiotic fiber, or placebo once daily for 4 weeks. Consumption of the fermented
milk containing probiotics and prebiotics resulted in a higher increase in the number of bowel movements and relieved constipation [<xref ref-type="bibr" rid="r138">138</xref>]. The
coexistence of prebiotics and probiotic microorganisms may be a therapeutic approach to the prevention and treatment of many diseases, including PD, in terms of the ability to regulate the
microbiota composition.</p>
</sec>
</sec>
<sec id="s6" sec-type="conclusions">
<title>CONCLUSION</title>
<p>Little is known about the role of the molecular causes of altered homeostasis in PD. However, in recent evidence, some motor and non-motor symptoms observed in PD may be attributed to
intestinal microbiota dysbiosis. PD patients are characterized by an altered gut microbiota composition and impairment of the intestinal barrier and enteric neuroimmune system that result in
enteric inflammation which contributes to neuroinflammation and neurodegeneration in CNS.</p>
<p>Recent advances have highlighted in the understanding of probiotic modulation of neurological and neuropsychiatric disorders via the gut-brain axis. The intestinal microbiota can directly or
indirectly alter the neurochemistry of the brain by influencing different physiological and behavioral outcomes through modulation of neuroendocrine pathways. The diversity and amount of
microorganisms in the gut may affect both the ENS and CNS. Therefore, a better understanding of the gut-brain axis may prevent the pathogenesis of the disease. In this context, dietary
approaches, probiotics, prebiotics, and synbiotics will play an important role. However, the studies conducted on the microbiota-gut-brain axis in patients with PD to date are inadequate, and
randomized controlled trials are needed to evaluate nutritional or probiotic supplementation for gut microbiota dysbiosis.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="r1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Toulouse</surname><given-names>A</given-names></name><name><surname>Sullivan</surname><given-names>AM</given-names></name></person-group>
<year>2008</year>
<article-title>Progress in Parkinson’s disease-where do we stand?</article-title><source/>Prog Neurobiol<volume> 85</volume>:
<fpage>376</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="pmid">18582530</pub-id></mixed-citation>
</ref>
<ref id="r2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Mulak</surname><given-names>A</given-names></name><name><surname>Bonaz</surname><given-names>B</given-names></name></person-group>
<year>2015</year>
<article-title>Brain-gut-microbiota axis in Parkinson’s disease</article-title>. <source/>World J Gastroenterol<volume> 21</volume>:
<fpage>10609</fpage>–<lpage>10620</lpage>. <pub-id pub-id-type="pmid">26457021</pub-id></mixed-citation>
</ref>
<ref id="r3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Shin</surname><given-names>CM</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name></person-group>
<year>2015</year>
<article-title>Characterization of gastrointestinal disorders in patients with parkinsonian syndromes</article-title>. <source/>Parkinsonism Relat
Disord<volume> 21</volume>: <fpage>455</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="pmid">25726518</pub-id></mixed-citation>
</ref>
<ref id="r4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<year>2018</year>
<article-title>Recent developments in understanding the role of the gut microbiota in brain health and disease</article-title>. <source/>Ann N Y Acad
Sci<volume> 1420</volume>: <fpage>5</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="pmid">28768369</pub-id></mixed-citation>
</ref>
<ref id="r5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Klingelhoefer</surname><given-names>L</given-names></name><name><surname>Reichmann</surname><given-names>H</given-names></name></person-group>
<year>2015</year>
<article-title>Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors</article-title>. <source/>Nat Rev Neurol<volume>
11</volume>: <fpage>625</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="pmid">26503923</pub-id></mixed-citation>
</ref>
<ref id="r6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Nair</surname><given-names>AT</given-names></name><name><surname>Ramachandran</surname><given-names>V</given-names></name><name><surname>Joghee</surname><given-names>NM</given-names></name><name><surname>Antony</surname><given-names>S</given-names></name><name><surname>Ramalingam</surname><given-names>G</given-names></name></person-group>
<year>2018</year>
<article-title>Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical
review</article-title>. <source/>J Neurogastroenterol Motil<volume> 24</volume>: <fpage>30</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="pmid">29291606</pub-id></mixed-citation>
</ref>
<ref id="r7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Scheperjans</surname><given-names>F</given-names></name><name><surname>Aho</surname><given-names>V</given-names></name><name><surname>Pereira</surname><given-names>PA</given-names></name><name><surname>Koskinen</surname><given-names>K</given-names></name><name><surname>Paulin</surname><given-names>L</given-names></name><name><surname>Pekkonen</surname><given-names>E</given-names></name><name><surname>Haapaniemi</surname><given-names>E</given-names></name><name><surname>Kaakkola</surname><given-names>S</given-names></name><name><surname>Eerola-Rautio</surname><given-names>J</given-names></name><name><surname>Pohja</surname><given-names>M</given-names></name><name><surname>Kinnunen</surname><given-names>E</given-names></name><name><surname>Murros</surname><given-names>K</given-names></name><name><surname>Auvinen</surname><given-names>P</given-names></name></person-group>
<year>2015</year>
<article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>. <source/>Mov Disord<volume> 30</volume>:
<fpage>350</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="pmid">25476529</pub-id></mixed-citation>
</ref>
<ref id="r8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Orimo</surname><given-names>S</given-names></name><name><surname>Ghebremedhin</surname><given-names>E</given-names></name><name><surname>Gelpi</surname><given-names>E</given-names></name></person-group>
<year>2018</year>
<article-title>Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology
during the course of sporadic PD?</article-title><source/>Cell Tissue Res<volume> 373</volume>: <fpage>267</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="pmid">29869180</pub-id></mixed-citation>
</ref>
<ref id="r9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Unger</surname><given-names>MM</given-names></name><name><surname>Spiegel</surname><given-names>J</given-names></name><name><surname>Dillmann</surname><given-names>KU</given-names></name><name><surname>Grundmann</surname><given-names>D</given-names></name><name><surname>Philippeit</surname><given-names>H</given-names></name><name><surname>Bürmann</surname><given-names>J</given-names></name><name><surname>Faßbender</surname><given-names>K</given-names></name><name><surname>Schwiertz</surname><given-names>A</given-names></name><name><surname>Schäfer</surname><given-names>KH</given-names></name></person-group>
<year>2016</year>
<article-title>Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls</article-title>.
<source/>Parkinsonism Relat Disord<volume> 32</volume>: <fpage>66</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="pmid">27591074</pub-id></mixed-citation>
</ref>
<ref id="r10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Clairembault</surname><given-names>T</given-names></name><name><surname>Leclair-Visonneau</surname><given-names>L</given-names></name><name><surname>Neunlist</surname><given-names>M</given-names></name><name><surname>Derkinderen</surname><given-names>P</given-names></name></person-group>
<year>2015</year>
<article-title>Enteric glial cells: new players in Parkinson’s disease?</article-title><source/>Mov Disord<volume> 30</volume>:
<fpage>494</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="pmid">25100667</pub-id></mixed-citation>
</ref>
<ref id="r11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Perez-Pardo</surname><given-names>P</given-names></name><name><surname>Hartog</surname><given-names>M</given-names></name><name><surname>Garssen</surname><given-names>J</given-names></name><name><surname>Kraneveld</surname><given-names>AD</given-names></name></person-group>
<year>2017</year>
<article-title>Microbes tickling your tummy: the importance of the gut-brain axis in Parkinson’s disease</article-title>. <source/>Curr Behav Neurosci
Rep<volume> 4</volume>: <fpage>361</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="pmid">29201595</pub-id></mixed-citation>
</ref>
<ref id="r12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Mayer</surname><given-names>EA</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Tillisch</surname><given-names>K</given-names></name></person-group>
<year>2014</year>
<article-title>Gut microbes and the brain: paradigm shift in neuroscience</article-title>. <source/>J Neurosci<volume> 34</volume>:
<fpage>15490</fpage>–<lpage>15496</lpage>. <pub-id pub-id-type="pmid">25392516</pub-id></mixed-citation>
</ref>
<ref id="r13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hill-Burns</surname><given-names>EM</given-names></name><name><surname>Debelius</surname><given-names>JW</given-names></name><name><surname>Morton</surname><given-names>JT</given-names></name><name><surname>Wissemann</surname><given-names>WT</given-names></name><name><surname>Lewis</surname><given-names>MR</given-names></name><name><surname>Wallen</surname><given-names>ZD</given-names></name><name><surname>Peddada</surname><given-names>SD</given-names></name><name><surname>Factor</surname><given-names>SA</given-names></name><name><surname>Molho</surname><given-names>E</given-names></name><name><surname>Zabetian</surname><given-names>CP</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Payami</surname><given-names>H</given-names></name></person-group>
<year>2017</year>
<article-title>Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome</article-title>. <source/>Mov
Disord<volume> 32</volume>: <fpage>739</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="pmid">28195358</pub-id></mixed-citation>
</ref>
<ref id="r14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name></person-group>
<year>2016</year>
<article-title>Alzheimer’s disease and gut microbiota</article-title>. <source/>Sci China Life Sci<volume> 59</volume>:
<fpage>1006</fpage>–<lpage>1023</lpage>. <pub-id pub-id-type="pmid">27566465</pub-id></mixed-citation>
</ref>
<ref id="r15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name></person-group>
<year>2017</year>
<article-title>The gut microbiota and Alzheimer’s disease</article-title>. <source/>J Alzheimers Dis<volume> 58</volume>:
<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="pmid">28372330</pub-id></mixed-citation>
</ref>
<ref id="r16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sandhu</surname><given-names>KV</given-names></name><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<year>2017</year>
<article-title>Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry</article-title>. <source/>Transl Res<volume>
179</volume>: <fpage>223</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="pmid">27832936</pub-id></mixed-citation>
</ref>
<ref id="r17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Hyland</surname><given-names>NP</given-names></name></person-group>
<year>2015</year>
<article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>.
<source/>Front Cell Neurosci<volume> 9</volume>: <fpage>392</fpage>. <pub-id pub-id-type="pmid">26528128</pub-id></mixed-citation>
</ref>
<ref id="r18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Jenkins</surname><given-names>TA</given-names></name><name><surname>Nguyen</surname><given-names>JC</given-names></name><name><surname>Polglaze</surname><given-names>KE</given-names></name><name><surname>Bertrand</surname><given-names>PP</given-names></name></person-group>
<year>2016</year>
<article-title>Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis</article-title>.
<source/>Nutrients<volume> 8</volume>: <fpage>56</fpage>. </mixed-citation>
</ref>
<ref id="r19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Perez-Pardo</surname><given-names>P</given-names></name><name><surname>Dodiya</surname><given-names>HB</given-names></name><name><surname>Broersen</surname><given-names>LM</given-names></name><name><surname>Douna</surname><given-names>H</given-names></name><name><surname>van Wijk</surname><given-names>N</given-names></name><name><surname>Lopes da Silva</surname><given-names>S</given-names></name><name><surname>Garssen</surname><given-names>J</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name><name><surname>Kraneveld</surname><given-names>AD</given-names></name></person-group>
<year>2018</year>
<article-title>Gut-brain and brain-gut axis in Parkinson’s disease models: Effects of a uridine and fish oil diet</article-title>. <source/>Nutr
Neurosci<volume> 21</volume>: <fpage>391</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="pmid">28276272</pub-id></mixed-citation>
</ref>
<ref id="r20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Keshavarzian</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>SJ</given-names></name><name><surname>Engen</surname><given-names>PA</given-names></name><name><surname>Voigt</surname><given-names>RM</given-names></name><name><surname>Naqib</surname><given-names>A</given-names></name><name><surname>Forsyth</surname><given-names>CB</given-names></name><name><surname>Mutlu</surname><given-names>E</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name></person-group>
<year>2015</year>
<article-title>Colonic bacterial composition in Parkinson’s disease</article-title>. <source/>Mov Disord<volume> 30</volume>:
<fpage>1351</fpage>–<lpage>1360</lpage>. <pub-id pub-id-type="pmid">26179554</pub-id></mixed-citation>
</ref>
<ref id="r21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Rajoka</surname><given-names>MSR</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Mehwish</surname><given-names>HM</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Shao</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name></person-group>
<year>2017</year>
<article-title>Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health</article-title>. <source/>Food
Science and Human Wellness<volume> 6</volume>: <fpage>121</fpage>–<lpage>130</lpage>. </mixed-citation>
</ref>
<ref id="r22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ankolekar</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Pinto</surname><given-names>MS</given-names></name><name><surname>Johnson</surname><given-names>K</given-names></name><name><surname>Labbe</surname><given-names>R</given-names></name><name><surname>Shetty</surname><given-names>K</given-names></name></person-group>
<year>2011</year>
<article-title>Inhibitory potential of tea polyphenolics and influence of extraction time against <italic>Helicobacter pylori</italic> and lack of
inhibition of beneficial lactic acid bacteria</article-title>. <source/>J Med Food<volume> 14</volume>: <fpage>1321</fpage>–<lpage>1329</lpage>. <pub-id pub-id-type="pmid">21663484</pub-id></mixed-citation>
</ref>
<ref id="r23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Alcalay</surname><given-names>RN</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Mejia-Santana</surname><given-names>H</given-names></name><name><surname>Cote</surname><given-names>L</given-names></name><name><surname>Marder</surname><given-names>KS</given-names></name><name><surname>Scarmeas</surname><given-names>N</given-names></name></person-group>
<year>2012</year>
<article-title>The association between Mediterranean diet adherence and Parkinson’s disease</article-title>. <source/>Mov Disord<volume>
27</volume>: <fpage>771</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="pmid">22314772</pub-id></mixed-citation>
</ref>
<ref id="r24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Garcia-Mantrana</surname><given-names>I</given-names></name><name><surname>Selma-Royo</surname><given-names>M</given-names></name><name><surname>Alcantara</surname><given-names>C</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name></person-group>
<year>2018</year>
<article-title>Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult
population</article-title>. <source/>Front Microbiol<volume> 9</volume>: <fpage>890</fpage>. <pub-id pub-id-type="pmid">29867803</pub-id></mixed-citation>
</ref>
<ref id="r25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Del Chierico</surname><given-names>F</given-names></name><name><surname>Vernocchi</surname><given-names>P</given-names></name><name><surname>Dallapiccola</surname><given-names>B</given-names></name><name><surname>Putignani</surname><given-names>L</given-names></name></person-group>
<year>2014</year>
<article-title>Mediterranean diet and health: food effects on gut microbiota and disease control</article-title>. <source/>Int J Mol Sci<volume>
15</volume>: <fpage>11678</fpage>–<lpage>11699</lpage>. <pub-id pub-id-type="pmid">24987952</pub-id></mixed-citation>
</ref>
<ref id="r26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Sandhu</surname><given-names>KV</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<year>2016</year>
<article-title>May the force be with you: the light and dark sides of the microbiota–gut–brain axis in neuropsychiatry</article-title>. <source/>CNS
Drugs<volume> 30</volume>: <fpage>1019</fpage>–<lpage>1041</lpage>. <pub-id pub-id-type="pmid">27417321</pub-id></mixed-citation>
</ref>
<ref id="r27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Marizzoni</surname><given-names>M</given-names></name><name><surname>Provasi</surname><given-names>S</given-names></name><name><surname>Cattaneo</surname><given-names>A</given-names></name><name><surname>Frisoni</surname><given-names>GB</given-names></name></person-group>
<year>2017</year>
<article-title>Microbiota and neurodegenerative diseases</article-title>. <source/>Curr Opin Neurol<volume> 30</volume>:
<fpage>630</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="pmid">28906270</pub-id></mixed-citation>
</ref>
<ref id="r28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Clapp</surname><given-names>M</given-names></name><name><surname>Aurora</surname><given-names>N</given-names></name><name><surname>Herrera</surname><given-names>L</given-names></name><name><surname>Bhatia</surname><given-names>M</given-names></name><name><surname>Wilen</surname><given-names>E</given-names></name><name><surname>Wakefield</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Gut microbiota’s effect on mental health: the gut-brain axis</article-title>. <source/>Clin Pract<volume> 7</volume>:
<fpage>987</fpage>. <pub-id pub-id-type="pmid">29071061</pub-id></mixed-citation>
</ref>
<ref id="r29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Bonaz</surname><given-names>BL</given-names></name><name><surname>Bernstein</surname><given-names>CN</given-names></name></person-group>
<year>2013</year>
<article-title>Brain-gut interactions in inflammatory bowel disease</article-title>. <source/>Gastroenterology<volume> 144</volume>:
<fpage>36</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="pmid">23063970</pub-id></mixed-citation>
</ref>
<ref id="r30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Agustí</surname><given-names>A</given-names></name><name><surname>García-Pardo</surname><given-names>MP</given-names></name><name><surname>López-Almela</surname><given-names>I</given-names></name><name><surname>Campillo</surname><given-names>I</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Romaní-Pérez</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group>
<year>2018</year>
<article-title>Interplay between the gut-brain axis, obesity and cognitive function</article-title>. <source/>Front Neurosci<volume> 12</volume>:
<fpage>155</fpage>. <pub-id pub-id-type="pmid">29615850</pub-id></mixed-citation>
</ref>
<ref id="r31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Diaz Heijtz</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Anuar</surname><given-names>F</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Björkholm</surname><given-names>B</given-names></name><name><surname>Samuelsson</surname><given-names>A</given-names></name><name><surname>Hibberd</surname><given-names>ML</given-names></name><name><surname>Forssberg</surname><given-names>H</given-names></name><name><surname>Pettersson</surname><given-names>S</given-names></name><name><surname>Hibberd</surname><given-names>ML</given-names></name><name><surname>Forssberg</surname><given-names>H</given-names></name><name><surname>Pettersson</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>. <source/>Proc Natl Acad Sci USA<volume>
108</volume>: <fpage>3047</fpage>–<lpage>3052</lpage>. <pub-id pub-id-type="pmid">21282636</pub-id></mixed-citation>
</ref>
<ref id="r32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<year>2014</year>
<article-title>Minireview: Gut microbiota: the neglected endocrine organ</article-title>. <source/>Mol Endocrinol<volume> 28</volume>:
<fpage>1221</fpage>–<lpage>1238</lpage>. <pub-id pub-id-type="pmid">24892638</pub-id></mixed-citation>
</ref>
<ref id="r33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Mittal</surname><given-names>R</given-names></name><name><surname>Debs</surname><given-names>LH</given-names></name><name><surname>Patel</surname><given-names>AP</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>O’Connor</surname><given-names>G</given-names></name><name><surname>Grati</surname><given-names>M</given-names></name><name><surname>Mittal</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Eshraghi</surname><given-names>AA</given-names></name><name><surname>Deo</surname><given-names>SK</given-names></name><name><surname>Daunert</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>XZ</given-names></name></person-group>
<year>2017</year>
<article-title>Neurotransmitters: the critical modulators regulating gut-brain axis</article-title>. <source/>J Cell Physiol<volume> 232</volume>:
<fpage>2359</fpage>–<lpage>2372</lpage>. <pub-id pub-id-type="pmid">27512962</pub-id></mixed-citation>
</ref>
<ref id="r34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sampson</surname><given-names>TR</given-names></name><name><surname>Debelius</surname><given-names>JW</given-names></name><name><surname>Thron</surname><given-names>T</given-names></name><name><surname>Janssen</surname><given-names>S</given-names></name><name><surname>Shastri</surname><given-names>GG</given-names></name><name><surname>Ilhan</surname><given-names>ZE</given-names></name><name><surname>Challis</surname><given-names>C</given-names></name><name><surname>Schretter</surname><given-names>CE</given-names></name><name><surname>Rocha</surname><given-names>S</given-names></name><name><surname>Gradinaru</surname><given-names>V</given-names></name><name><surname>Chesselet</surname><given-names>MF</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Krajmalnik-Brown</surname><given-names>R</given-names></name><name><surname>Wittung-Stafshede</surname><given-names>P</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>
<year>2016</year>
<article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease</article-title>.
<source/>Cell<volume> 167</volume>: <fpage>1469</fpage>–<lpage>1480.e12</lpage>. <pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="r35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Spielman</surname><given-names>LJ</given-names></name><name><surname>Gibson</surname><given-names>DL</given-names></name><name><surname>Klegeris</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases</article-title>. <source/>Neurochem
Int<volume> 120</volume>: <fpage>149</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="pmid">30114473</pub-id></mixed-citation>
</ref>
<ref id="r36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Shen</surname><given-names>YQ</given-names></name></person-group>
<year>2018</year>
<article-title>Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s disease</article-title>. <source/>Ageing Res Rev<volume>
45</volume>: <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="pmid">29705121</pub-id></mixed-citation>
</ref>
<ref id="r37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hasegawa</surname><given-names>S</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Okuno</surname><given-names>T</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Nomoto</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>A</given-names></name><name><surname>Fujisawa</surname><given-names>Y</given-names></name><name><surname>Minato</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>A</given-names></name><name><surname>Ohno</surname><given-names>K</given-names></name><name><surname>Hirayama</surname><given-names>M</given-names></name></person-group>
<year>2015</year>
<article-title>Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease</article-title>. <source/>PLoS
One<volume> 10</volume>: <fpage>e0142164</fpage>. <pub-id pub-id-type="pmid">26539989</pub-id></mixed-citation>
</ref>
<ref id="r38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Petrov</surname><given-names>VA</given-names></name><name><surname>Saltykova</surname><given-names>IV</given-names></name><name><surname>Zhukova</surname><given-names>IA</given-names></name><name><surname>Alifirova</surname><given-names>VM</given-names></name><name><surname>Zhukova</surname><given-names>NG</given-names></name><name><surname>Dorofeeva</surname><given-names>YB</given-names></name><name><surname>Tyakht</surname><given-names>AV</given-names></name><name><surname>Kovarsky</surname><given-names>BA</given-names></name><name><surname>Alekseev</surname><given-names>DG</given-names></name><name><surname>Kostryukova</surname><given-names>ES</given-names></name><name><surname>Mironova</surname><given-names>YS</given-names></name><name><surname>Izhboldina</surname><given-names>OP</given-names></name><name><surname>Nikitina</surname><given-names>MA</given-names></name><name><surname>Perevozchikova</surname><given-names>TV</given-names></name><name><surname>Fait</surname><given-names>EA</given-names></name><name><surname>Babenko</surname><given-names>VV</given-names></name><name><surname>Vakhitova</surname><given-names>MT</given-names></name><name><surname>Govorun</surname><given-names>VM</given-names></name><name><surname>Sazonov</surname><given-names>AE</given-names></name></person-group>
<year>2017</year>
<article-title>Analysis of gut microbiota in patients with Parkinson’s disease</article-title>. <source/>Bull Exp Biol Med<volume> 162</volume>:
<fpage>734</fpage>–<lpage>737</lpage>. <pub-id pub-id-type="pmid">28429209</pub-id></mixed-citation>
</ref>
<ref id="r39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name></person-group>
<year>2018</year>
<article-title>Gut microbiota in patients with Parkinson’s disease in southern China</article-title>. <source/>Parkinsonism Relat Disord<volume>
53</volume>: <fpage>82</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="pmid">29776865</pub-id></mixed-citation>
</ref>
<ref id="r40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>SD</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name></person-group>
<year>2018</year>
<article-title>Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease</article-title>. <source/>Brain Behav Immun<volume>
70</volume>: <fpage>194</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="pmid">29501802</pub-id></mixed-citation>
</ref>
<ref id="r41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Liang</surname><given-names>S</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Qin</surname><given-names>B</given-names></name></person-group>
<year>2017</year>
<article-title>Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features</article-title>. <source/>Sci China
Life Sci<volume> 60</volume>: <fpage>1223</fpage>–<lpage>1233</lpage>. <pub-id pub-id-type="pmid">28536926</pub-id></mixed-citation>
</ref>
<ref id="r42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hopfner</surname><given-names>F</given-names></name><name><surname>Künstner</surname><given-names>A</given-names></name><name><surname>Müller</surname><given-names>SH</given-names></name><name><surname>Künzel</surname><given-names>S</given-names></name><name><surname>Zeuner</surname><given-names>KE</given-names></name><name><surname>Margraf</surname><given-names>NG</given-names></name><name><surname>Deuschl</surname><given-names>G</given-names></name><name><surname>Baines</surname><given-names>JF</given-names></name><name><surname>Kuhlenbäumer</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>Gut microbiota in Parkinson disease in a northern German cohort</article-title>. <source/>Brain Res<volume> 1667</volume>:
<fpage>41</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="pmid">28506555</pub-id></mixed-citation>
</ref>
<ref id="r43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Heintz-Buschart</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>U</given-names></name><name><surname>Wicke</surname><given-names>T</given-names></name><name><surname>Sixel-Döring</surname><given-names>F</given-names></name><name><surname>Janzen</surname><given-names>A</given-names></name><name><surname>Sittig-Wiegand</surname><given-names>E</given-names></name><name><surname>Trenkwalder</surname><given-names>C</given-names></name><name><surname>Oertel</surname><given-names>WH</given-names></name><name><surname>Mollenhauer</surname><given-names>B</given-names></name><name><surname>Wilmes</surname><given-names>P</given-names></name></person-group>
<year>2018</year>
<article-title>The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder</article-title>. <source/>Mov
Disord<volume> 33</volume>: <fpage>88</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="pmid">28843021</pub-id></mixed-citation>
</ref>
<ref id="r44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Bedarf</surname><given-names>JR</given-names></name><name><surname>Hildebrand</surname><given-names>F</given-names></name><name><surname>Coelho</surname><given-names>LP</given-names></name><name><surname>Sunagawa</surname><given-names>S</given-names></name><name><surname>Bahram</surname><given-names>M</given-names></name><name><surname>Goeser</surname><given-names>F</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Wüllner</surname><given-names>U</given-names></name></person-group>
<year>2017</year>
<article-title>Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease
patients</article-title>. <source/>Genome Med<volume> 9</volume>: <fpage>39</fpage>. <pub-id pub-id-type="pmid">28449715</pub-id></mixed-citation>
</ref>
<ref id="r45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Lopetuso</surname><given-names>LR</given-names></name><name><surname>Napoli</surname><given-names>M</given-names></name><name><surname>Rizzatti</surname><given-names>G</given-names></name><name><surname>Scaldaferri</surname><given-names>F</given-names></name><name><surname>Franceschi</surname><given-names>F</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Considering gut microbiota disturbance in the management of <italic>Helicobacter pylori</italic> infection</article-title>. <source/>Expert
Rev Gastroenterol Hepatol<volume> 12</volume>: <fpage>899</fpage>–<lpage>906</lpage>. <pub-id pub-id-type="pmid">30040500</pub-id></mixed-citation>
</ref>
<ref id="r46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Schütte</surname><given-names>K</given-names></name><name><surname>Koch</surname><given-names>N</given-names></name><name><surname>Vilchez-Vargas</surname><given-names>R</given-names></name><name><surname>Wos-Oxley</surname><given-names>ML</given-names></name><name><surname>Oxley</surname><given-names>APA</given-names></name><name><surname>Vital</surname><given-names>M</given-names></name><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Pieper</surname><given-names>DH</given-names></name></person-group>
<year>2018</year>
<article-title>The active bacterial assemblages of the upper GI tract in individuals with and without <italic>Helicobacter</italic>
infection</article-title>. <source/>Gut<volume> 67</volume>: <fpage>216</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="pmid">27920199</pub-id></mixed-citation>
</ref>
<ref id="r47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Vizcarra</surname><given-names>JA</given-names></name><name><surname>Wilson-Perez</surname><given-names>HE</given-names></name><name><surname>Espay</surname><given-names>AJ</given-names></name></person-group>
<year>2015</year>
<article-title>The power in numbers: gut microbiota in Parkinson’s disease</article-title>. <source/>Mov Disord<volume> 30</volume>:
<fpage>296</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="pmid">25545262</pub-id></mixed-citation>
</ref>
<ref id="r48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ghaisas</surname><given-names>S</given-names></name><name><surname>Maher</surname><given-names>J</given-names></name><name><surname>Kanthasamy</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and
neurodegenerative diseases</article-title>. <source/>Pharmacol Ther<volume> 158</volume>: <fpage>52</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="pmid">26627987</pub-id></mixed-citation>
</ref>
<ref id="r49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Evrensel</surname><given-names>A</given-names></name><name><surname>Ceylan</surname><given-names>ME</given-names></name></person-group>
<year>2016</year>
<article-title>Fecal microbiota transplantation and its usage in neuropsychiatric disorders</article-title>. <source/>Clin Psychopharmacol
Neurosci<volume> 14</volume>: <fpage>231</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="pmid">27489376</pub-id></mixed-citation>
</ref>
<ref id="r50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sun</surname><given-names>MF</given-names></name><name><surname>Zhu</surname><given-names>YL</given-names></name><name><surname>Zhou</surname><given-names>ZL</given-names></name><name><surname>Jia</surname><given-names>XB</given-names></name><name><surname>Xu</surname><given-names>YD</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>YQ</given-names></name></person-group>
<year>2018</year>
<article-title>Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and
TLR4/TNF-α signaling pathway</article-title>. <source/>Brain Behav Immun<volume> 70</volume>: <fpage>48</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="pmid">29471030</pub-id></mixed-citation>
</ref>
<ref id="r51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Jones</surname><given-names>JM</given-names></name></person-group>
<year>2014</year>
<article-title>CODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’</article-title>. <source/>Nutr J<volume> 13</volume>:
<fpage>34</fpage>. <pub-id pub-id-type="pmid">24725724</pub-id></mixed-citation>
</ref>
<ref id="r52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Lombardi</surname><given-names>VC</given-names></name><name><surname>De Meirleir</surname><given-names>KL</given-names></name><name><surname>Subramanian</surname><given-names>K</given-names></name><name><surname>Nourani</surname><given-names>SM</given-names></name><name><surname>Dagda</surname><given-names>RK</given-names></name><name><surname>Delaney</surname><given-names>SL</given-names></name><name><surname>Palotás</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and
neuroinflammatory disease</article-title>. <source/>J Nutr Biochem<volume> 61</volume>: <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="pmid">29886183</pub-id></mixed-citation>
</ref>
<ref id="r53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>Grant</surname><given-names>LJ</given-names></name><name><surname>Gidley</surname><given-names>MJ</given-names></name><name><surname>Mikkelsen</surname><given-names>D</given-names></name></person-group>
<year>2017</year>
<article-title>Gut fermentation of dietary fibres: physico-chemistry of plant cell walls and implications for health</article-title>. <source/>Int J Mol
Sci<volume> 18</volume>: <fpage>2203</fpage>. </mixed-citation>
</ref>
<ref id="r54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group><name><surname>van de Wouw</surname><given-names>M</given-names></name><name><surname>Schellekens</surname><given-names>H</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<year>2017</year>
<article-title>Microbiota-gut-brain axis: modulator of host metabolism and appetite</article-title>. <source/>J Nutr<volume> 147</volume>:
<fpage>727</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="pmid">28356427</pub-id></mixed-citation>
</ref>
<ref id="r55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Verbeke</surname><given-names>K</given-names></name><name><surname>Ferchaud-Roucher</surname><given-names>V</given-names></name><name><surname>Preston</surname><given-names>T</given-names></name><name><surname>Small</surname><given-names>AC</given-names></name><name><surname>Henckaerts</surname><given-names>L</given-names></name><name><surname>Krempf</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Vonk</surname><given-names>RJ</given-names></name><name><surname>Priebe</surname><given-names>MG</given-names></name></person-group>
<year>2010</year>
<article-title>Influence of the type of indigestible carbohydrate on plasma and urine short-chain fatty acid profiles in healthy human
volunteers</article-title>. <source/>Eur J Clin Nutr<volume> 64</volume>: <fpage>678</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="pmid">20502475</pub-id></mixed-citation>
</ref>
<ref id="r56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Arumugam</surname><given-names>M</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Pelletier</surname><given-names>E</given-names></name><name><surname>Le Paslier</surname><given-names>D</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Mende</surname><given-names>DR</given-names></name><name><surname>Fernandes</surname><given-names>GR</given-names></name><name><surname>Tap</surname><given-names>J</given-names></name><name><surname>Bruls</surname><given-names>T</given-names></name><name><surname>Batto</surname><given-names>JM</given-names></name><name><surname>Bertalan</surname><given-names>M</given-names></name><name><surname>Borruel</surname><given-names>N</given-names></name><name><surname>Casellas</surname><given-names>F</given-names></name><name><surname>Fernandez</surname><given-names>L</given-names></name><name><surname>Gautier</surname><given-names>L</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Hattori</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Kleerebezem</surname><given-names>M</given-names></name><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Leclerc</surname><given-names>M</given-names></name><name><surname>Levenez</surname><given-names>F</given-names></name><name><surname>Manichanh</surname><given-names>C</given-names></name><name><surname>Nielsen</surname><given-names>HB</given-names></name><name><surname>Nielsen</surname><given-names>T</given-names></name><name><surname>Pons</surname><given-names>N</given-names></name><name><surname>Poulain</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Sicheritz-Ponten</surname><given-names>T</given-names></name><name><surname>Tims</surname><given-names>S</given-names></name><name><surname>Torrents</surname><given-names>D</given-names></name><name><surname>Ugarte</surname><given-names>E</given-names></name><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>Doré</surname><given-names>J</given-names></name><name><surname>Antolín</surname><given-names>M</given-names></name><name><surname>Artiguenave</surname><given-names>F</given-names></name><name><surname>Blottiere</surname><given-names>HM</given-names></name><name><surname>Almeida</surname><given-names>M</given-names></name><name><surname>Brechot</surname><given-names>C</given-names></name><name><surname>Cara</surname><given-names>C</given-names></name><name><surname>Chervaux</surname><given-names>C</given-names></name><name><surname>Cultrone</surname><given-names>A</given-names></name><name><surname>Delorme</surname><given-names>C</given-names></name><name><surname>Denariaz</surname><given-names>G</given-names></name><name><surname>Dervyn</surname><given-names>R</given-names></name><name><surname>Foerstner</surname><given-names>KU</given-names></name><name><surname>Friss</surname><given-names>C</given-names></name><name><surname>van de Guchte</surname><given-names>M</given-names></name><name><surname>Guedon</surname><given-names>E</given-names></name><name><surname>Haimet</surname><given-names>F</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>van Hylckama-Vlieg</surname><given-names>J</given-names></name><name><surname>Jamet</surname><given-names>A</given-names></name><name><surname>Juste</surname><given-names>C</given-names></name><name><surname>Kaci</surname><given-names>G</given-names></name><name><surname>Knol</surname><given-names>J</given-names></name><name><surname>Lakhdari</surname><given-names>O</given-names></name><name><surname>Layec</surname><given-names>S</given-names></name><name><surname>Le Roux</surname><given-names>K</given-names></name><name><surname>Maguin</surname><given-names>E</given-names></name><name><surname>Mérieux</surname><given-names>A</given-names></name><name><surname>Melo Minardi</surname><given-names>R</given-names></name><name><surname>M’rini</surname><given-names>C</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Oozeer</surname><given-names>R</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Renault</surname><given-names>P</given-names></name><name><surname>Rescigno</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>N</given-names></name><name><surname>Sunagawa</surname><given-names>S</given-names></name><name><surname>Torrejon</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>K</given-names></name><name><surname>Vandemeulebrouck</surname><given-names>G</given-names></name><name><surname>Varela</surname><given-names>E</given-names></name><name><surname>Winogradsky</surname><given-names>Y</given-names></name><name><surname>Zeller</surname><given-names>G</given-names></name><name><surname>Weissenbach</surname><given-names>J</given-names></name><name><surname>Ehrlich</surname><given-names>SD</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group>, MetaHIT Consortium.<year>2011</year>
<article-title>Enterotypes of the human gut microbiome</article-title>. <source/>Nature<volume> 473</volume>:
<fpage>174</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="pmid">21508958</pub-id></mixed-citation>
</ref>
<ref id="r57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Forsyth</surname><given-names>CB</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Kordower</surname><given-names>JH</given-names></name><name><surname>Voigt</surname><given-names>RM</given-names></name><name><surname>Shaikh</surname><given-names>M</given-names></name><name><surname>Jaglin</surname><given-names>JA</given-names></name><name><surname>Estes</surname><given-names>JD</given-names></name><name><surname>Dodiya</surname><given-names>HB</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early
Parkinson’s disease</article-title>. <source/>PLoS One<volume> 6</volume>: <fpage>e28032</fpage>. <pub-id pub-id-type="pmid">22145021</pub-id></mixed-citation>
</ref>
<ref id="r58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Kelly</surname><given-names>LP</given-names></name><name><surname>Carvey</surname><given-names>PM</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name><name><surname>Shannon</surname><given-names>KM</given-names></name><name><surname>Shaikh</surname><given-names>M</given-names></name><name><surname>Bakay</surname><given-names>RA</given-names></name><name><surname>Kordower</surname><given-names>JH</given-names></name></person-group>
<year>2014</year>
<article-title>Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease</article-title>.
<source/>Mov Disord<volume> 29</volume>: <fpage>999</fpage>–<lpage>1009</lpage>. <pub-id pub-id-type="pmid">24898698</pub-id></mixed-citation>
</ref>
<ref id="r59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Tan</surname><given-names>LC</given-names></name><name><surname>Methawasin</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>EK</given-names></name><name><surname>Tan</surname><given-names>JH</given-names></name><name><surname>Au</surname><given-names>WL</given-names></name><name><surname>Yuan</surname><given-names>JM</given-names></name><name><surname>Koh</surname><given-names>WP</given-names></name></person-group>
<year>2016</year>
<article-title>Dietary cholesterol, fats and risk of Parkinson’s disease in the Singapore Chinese Health Study</article-title>. <source/>J Neurol Neurosurg
Psychiatry<volume> 87</volume>: <fpage>86</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="pmid">25669745</pub-id></mixed-citation>
</ref>
<ref id="r60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>W</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Tsuboi</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Oeda</surname><given-names>T</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Sakae</surname><given-names>N</given-names></name><name><surname>Fukuyama</surname><given-names>H</given-names></name><name><surname>Hirota</surname><given-names>Y</given-names></name><name><surname>Nagai</surname><given-names>M</given-names></name></person-group>, Fukuoka Kinki Parkinson’s Disease Study Group.<year>2010</year>
<article-title>Dietary fat intake and risk of Parkinson’s disease: a case-control study in
Japan</article-title>. <source/>J Neurol Sci<volume> 288</volume>: <fpage>117</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="pmid">19819467</pub-id></mixed-citation>
</ref>
<ref id="r61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Gomez-Pinilla</surname><given-names>F</given-names></name></person-group>
<year>2004</year>
<article-title>Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury
in rats</article-title>. <source/>J Neurotrauma<volume> 21</volume>: <fpage>1457</fpage>–<lpage>1467</lpage>. <pub-id pub-id-type="pmid">15672635</pub-id></mixed-citation>
</ref>
<ref id="r62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Kikuta</surname><given-names>T</given-names></name><name><surname>Shibata</surname><given-names>H</given-names></name><name><surname>Shido</surname><given-names>O</given-names></name></person-group>
<year>2005</year>
<article-title>Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid β-infused
rats</article-title>. <source/>J Nutr<volume> 135</volume>: <fpage>549</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="pmid">15735092</pub-id></mixed-citation>
</ref>
<ref id="r63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Pu</surname><given-names>S</given-names></name><name><surname>Khazanehei</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>PJ</given-names></name><name><surname>Khafipour</surname><given-names>E</given-names></name></person-group>
<year>2016</year>
<article-title>Interactions between obesity status and dietary intake of monounsaturated and polyunsaturated oils on human gut microbiome profiles in the
canola oil multicenter intervention trial (COMIT)</article-title>. <source/>Front Microbiol<volume> 7</volume>: <fpage>1612</fpage>. <pub-id pub-id-type="pmid">27777570</pub-id></mixed-citation>
</ref>
<ref id="r64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Noriega</surname><given-names>BS</given-names></name><name><surname>Sanchez-Gonzalez</surname><given-names>MA</given-names></name><name><surname>Salyakina</surname><given-names>D</given-names></name><name><surname>Coffman</surname><given-names>J</given-names></name></person-group>
<year>2016</year>
<article-title>Understanding the impact of omega-3 rich diet on the gut microbiota</article-title>. <source/>Case Rep Med<volume> 2016</volume>:
<fpage>3089303</fpage>. <pub-id pub-id-type="pmid">27065349</pub-id></mixed-citation>
</ref>
<ref id="r65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Byerley</surname><given-names>LO</given-names></name><name><surname>Samuelson</surname><given-names>D</given-names></name><name><surname>Blanchard</surname><given-names>E</given-names><suffix>4th</suffix></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Lorenzen</surname><given-names>BN</given-names></name><name><surname>Banks</surname><given-names>S</given-names></name><name><surname>Ponder</surname><given-names>MA</given-names></name><name><surname>Welsh</surname><given-names>DA</given-names></name><name><surname>Taylor</surname><given-names>CM</given-names></name></person-group>
<year>2017</year>
<article-title>Changes in the gut microbial communities following addition of walnuts to the diet</article-title>. <source/>J Nutr Biochem<volume>
48</volume>: <fpage>94</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="pmid">28797931</pub-id></mixed-citation>
</ref>
<ref id="r66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Miller</surname><given-names>RL</given-names></name><name><surname>James-Kracke</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>GY</given-names></name><name><surname>Sun</surname><given-names>AY</given-names></name></person-group>
<year>2009</year>
<article-title>Oxidative and inflammatory pathways in Parkinson’s disease</article-title>. <source/>Neurochem Res<volume> 34</volume>:
<fpage>55</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="pmid">18363100</pub-id></mixed-citation>
</ref>
<ref id="r67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Holmqvist</surname><given-names>S</given-names></name><name><surname>Chutna</surname><given-names>O</given-names></name><name><surname>Bousset</surname><given-names>L</given-names></name><name><surname>Aldrin-Kirk</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Björklund</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Roybon</surname><given-names>L</given-names></name><name><surname>Melki</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>JY</given-names></name></person-group>
<year>2014</year>
<article-title>Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats</article-title>. <source/>Acta
Neuropathol<volume> 128</volume>: <fpage>805</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="pmid">25296989</pub-id></mixed-citation>
</ref>
<ref id="r68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Kamel</surname><given-names>F</given-names></name><name><surname>Goldman</surname><given-names>SM</given-names></name><name><surname>Umbach</surname><given-names>DM</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>G</given-names></name><name><surname>Barber</surname><given-names>MR</given-names></name><name><surname>Meng</surname><given-names>C</given-names></name><name><surname>Marras</surname><given-names>C</given-names></name><name><surname>Korell</surname><given-names>M</given-names></name><name><surname>Kasten</surname><given-names>M</given-names></name><name><surname>Hoppin</surname><given-names>JA</given-names></name><name><surname>Comyns</surname><given-names>K</given-names></name><name><surname>Chade</surname><given-names>A</given-names></name><name><surname>Blair</surname><given-names>A</given-names></name><name><surname>Bhudhikanok</surname><given-names>GS</given-names></name><name><surname>Webster Ross</surname><given-names>G</given-names></name><name><surname>William Langston</surname><given-names>J</given-names></name><name><surname>Sandler</surname><given-names>DP</given-names></name><name><surname>Tanner</surname><given-names>CM</given-names></name></person-group>
<year>2014</year>
<article-title>Dietary fat intake, pesticide use, and Parkinson’s disease</article-title>. <source/>Parkinsonism Relat Disord<volume> 20</volume>:
<fpage>82</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="pmid">24120951</pub-id></mixed-citation>
</ref>
<ref id="r69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Pandey</surname><given-names>KB</given-names></name><name><surname>Rizvi</surname><given-names>SI</given-names></name></person-group>
<year>2009</year>
<article-title>Plant polyphenols as dietary antioxidants in human health and disease</article-title>. <source/>Oxid Med Cell Longev<volume>
2</volume>: <fpage>270</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="pmid">20716914</pub-id></mixed-citation>
</ref>
<ref id="r70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Neveu</surname><given-names>V</given-names></name><name><surname>Perez-Jiménez</surname><given-names>J</given-names></name><name><surname>Vos</surname><given-names>F</given-names></name><name><surname>Crespy</surname><given-names>V</given-names></name><name><surname>du Chaffaut</surname><given-names>L</given-names></name><name><surname>Mennen</surname><given-names>L</given-names></name><name><surname>Knox</surname><given-names>C</given-names></name><name><surname>Eisner</surname><given-names>R</given-names></name><name><surname>Cruz</surname><given-names>J</given-names></name><name><surname>Wishart</surname><given-names>D</given-names></name><name><surname>Scalbert</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Phenol-Explorer: an online comprehensive database on polyphenol contents in foods</article-title>. <source/>Database
(Oxford)<volume> 2010</volume>: <fpage>bap024</fpage>. <pub-id pub-id-type="pmid">20428313</pub-id></mixed-citation>
</ref>
<ref id="r71">
<label>71</label>
<mixed-citation publication-type="other"><person-group><name><surname>Andrés-Lacueva</surname><given-names>C</given-names></name><name><surname>Medina-Remon</surname><given-names>A</given-names></name><name><surname>Llorach</surname><given-names>R</given-names></name><name><surname>Urpi-Sarda</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Chiva-Blanch</surname><given-names>G</given-names></name><name><surname>Zamora-Ros</surname><given-names>R</given-names></name><name><surname>Rotches-Ribalta</surname><given-names>M</given-names></name><name><surname>Lamuela-Raventos</surname><given-names>RM</given-names></name></person-group>
<year>2010</year>. Phenolic compounds: chemistry and occurrence in fruits and vegetables. Fruit and vegetable phytochemicals: Chemistry, nutritional value and stability.
53–80.</mixed-citation>
</ref>
<ref id="r72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Serra</surname><given-names>D</given-names></name><name><surname>Almeida</surname><given-names>LM</given-names></name><name><surname>Dinis</surname><given-names>TC</given-names></name></person-group>
<year>2018</year>
<article-title>Dietary polyphenols: a novel strategy to modulate microbiota-gut-brain axis</article-title>. <source/>Trends Food Sci
Technol<volume> 78</volume>: <fpage>224</fpage>–<lpage>233</lpage>. </mixed-citation>
</ref>
<ref id="r73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Manach</surname><given-names>C</given-names></name><name><surname>Williamson</surname><given-names>G</given-names></name><name><surname>Morand</surname><given-names>C</given-names></name><name><surname>Scalbert</surname><given-names>A</given-names></name><name><surname>Rémésy</surname><given-names>C</given-names></name></person-group>
<year>2005</year>
<article-title>Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies</article-title>. <source/>Am J Clin
Nutr<volume> 81</volume><issue>Suppl</issue>: <fpage>230S</fpage>–<lpage>242S</lpage>. <pub-id pub-id-type="pmid">15640486</pub-id></mixed-citation>
</ref>
<ref id="r74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Cardona</surname><given-names>F</given-names></name><name><surname>Andrés-Lacueva</surname><given-names>C</given-names></name><name><surname>Tulipani</surname><given-names>S</given-names></name><name><surname>Tinahones</surname><given-names>FJ</given-names></name><name><surname>Queipo-Ortuño</surname><given-names>MI</given-names></name></person-group>
<year>2013</year>
<article-title>Benefits of polyphenols on gut microbiota and implications in human health</article-title>. <source/>J Nutr Biochem<volume>
24</volume>: <fpage>1415</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="pmid">23849454</pub-id></mixed-citation>
</ref>
<ref id="r75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Mayta-Apaza</surname><given-names>AC</given-names></name><name><surname>Pottgen</surname><given-names>E</given-names></name><name><surname>De Bodt</surname><given-names>J</given-names></name><name><surname>Papp</surname><given-names>N</given-names></name><name><surname>Marasini</surname><given-names>D</given-names></name><name><surname>Howard</surname><given-names>L</given-names></name><name><surname>Abranko</surname><given-names>L</given-names></name><name><surname>Van de Wiele</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>SO</given-names></name><name><surname>Carbonero</surname><given-names>F</given-names></name></person-group>
<year>2018</year>
<article-title>Impact of tart cherries polyphenols on the human gut microbiota and phenolic metabolites in vitro and in vivo</article-title>. <source/>J
Nutr Biochem<volume> 59</volume>: <fpage>160</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="pmid">30055451</pub-id></mixed-citation>
</ref>
<ref id="r76">
<label>76</label>
<mixed-citation publication-type="book"><person-group><name><surname>Popa</surname><given-names>DE</given-names></name><name><surname>Drăgoi</surname><given-names>CM</given-names></name><name><surname>Arsene</surname><given-names>AL</given-names></name><name><surname>Dumitrescu</surname><given-names>IB</given-names></name><name><surname>Nicolae</surname><given-names>AC</given-names></name><name><surname>Velescu</surname><given-names>BS</given-names></name><name><surname>Burcea-Dragomiroiu</surname><given-names>GT</given-names></name></person-group>
<year>2017</year>. The relationship between phenolic compounds from diet and microbiota. In Phenolic Compounds-Biological Activity.</mixed-citation>
</ref>
<ref id="r77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Espín</surname><given-names>JC</given-names></name><name><surname>González-Sarrías</surname><given-names>A</given-names></name><name><surname>Tomás-Barberán</surname><given-names>FA</given-names></name></person-group>
<year>2017</year>
<article-title>The gut microbiota: a key factor in the therapeutic effects of (poly)phenols</article-title>. <source/>Biochem Pharmacol<volume>
139</volume>: <fpage>82</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="pmid">28483461</pub-id></mixed-citation>
</ref>
<ref id="r78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ozdal</surname><given-names>T</given-names></name><name><surname>Sela</surname><given-names>DA</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Boyacıoğlu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Capanoglu</surname><given-names>E</given-names></name></person-group>
<year>2016</year>
<article-title>The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility</article-title>.
<source/>Nutrients<volume> 8</volume>: <fpage>78</fpage>. <pub-id pub-id-type="pmid">26861391</pub-id></mixed-citation>
</ref>
<ref id="r79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Dudek-Wicher</surname><given-names>RK</given-names></name><name><surname>Junka</surname><given-names>A</given-names></name><name><surname>Bartoszewicz</surname><given-names>M</given-names></name></person-group>
<year>2018</year>
<article-title>The influence of antibiotics and dietary components on gut microbiota</article-title>. <source/>Prz Gastroenterol<volume>
13</volume>: <fpage>85</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="pmid">30002765</pub-id></mixed-citation>
</ref>
<ref id="r80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Mahendran</surname><given-names>G</given-names></name><name><surname>Manoj</surname><given-names>M</given-names></name><name><surname>Prasad</surname><given-names>KR</given-names></name><name><surname>Bai</surname><given-names>VN</given-names></name></person-group>
<year>2015</year>
<article-title>Antioxidants, anti-proliferative, anti-inflammatory, anti-diabetic and anti-microbial effects of isolated compounds from Swertia corymbosa
(Grieb.) Wight ex CB Clark—an in vitro approach</article-title>. <source/>Food Science and Human Wellness<volume> 4</volume>: <fpage>169</fpage>–<lpage>179</lpage>.
</mixed-citation>
</ref>
<ref id="r81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Vauzour</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial
effects</article-title>. <source/>Oxid Med Cell Longev<volume> 2012</volume>: <fpage>914273</fpage>. <pub-id pub-id-type="pmid">22701758</pub-id></mixed-citation>
</ref>
<ref id="r82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Shigemune</surname><given-names>N</given-names></name><name><surname>Tsugukuni</surname><given-names>T</given-names></name><name><surname>Jun</surname><given-names>H</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><name><surname>Mekada</surname><given-names>Y</given-names></name><name><surname>Kurahachi</surname><given-names>M</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name></person-group>
<year>2012</year>
<article-title>Mechanism of the combined anti-bacterial effect of green tea extract and NaCl against <italic>Staphylococcus aureus</italic> and
<italic>Escherichia coli</italic> O157: H7</article-title>. <source/>Food Control<volume> 25</volume>: <fpage>225</fpage>–<lpage>232</lpage>. </mixed-citation>
</ref>
<ref id="r83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Bae</surname><given-names>EA</given-names></name><name><surname>Han</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group>
<year>1999</year>
<article-title>In vitro anti-<italic>Helicobacter pylori</italic> activity of some flavonoids and their metabolites</article-title>. <source/>Planta
Med<volume> 65</volume>: <fpage>442</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="pmid">10454900</pub-id></mixed-citation>
</ref>
<ref id="r84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Queipo-Ortuño</surname><given-names>MI</given-names></name><name><surname>Boto-Ordóñez</surname><given-names>M</given-names></name><name><surname>Murri</surname><given-names>M</given-names></name><name><surname>Gomez-Zumaquero</surname><given-names>JM</given-names></name><name><surname>Clemente-Postigo</surname><given-names>M</given-names></name><name><surname>Estruch</surname><given-names>R</given-names></name><name><surname>Cardona Diaz</surname><given-names>F</given-names></name><name><surname>Andrés-Lacueva</surname><given-names>C</given-names></name><name><surname>Tinahones</surname><given-names>FJ</given-names></name></person-group>
<year>2012</year>
<article-title>Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers</article-title>. <source/>Am J Clin
Nutr<volume> 95</volume>: <fpage>1323</fpage>–<lpage>1334</lpage>. <pub-id pub-id-type="pmid">22552027</pub-id></mixed-citation>
</ref>
<ref id="r85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ho</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Ruan</surname><given-names>K</given-names></name><name><surname>Mogno</surname><given-names>I</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Carry</surname><given-names>E</given-names></name><name><surname>Brathwaite</surname><given-names>J</given-names></name><name><surname>Sims</surname><given-names>S</given-names></name><name><surname>Frolinger</surname><given-names>T</given-names></name><name><surname>Westfall</surname><given-names>S</given-names></name><name><surname>Mazzola</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Hao</surname><given-names>K</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name><name><surname>Simon</surname><given-names>JE</given-names></name><name><surname>Faith</surname><given-names>J</given-names></name><name><surname>Pasinetti</surname><given-names>GM</given-names></name></person-group>
<year>2019</year>
<article-title>Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity</article-title>. <source/>J
Nutr Biochem<volume> 64</volume>: <fpage>170</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="pmid">30530257</pub-id></mixed-citation>
</ref>
<ref id="r86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Huang</surname><given-names>HK</given-names></name><name><surname>Wang</surname><given-names>JH</given-names></name><name><surname>Lei</surname><given-names>WY</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><name><surname>Chang</surname><given-names>CY</given-names></name><name><surname>Liou</surname><given-names>LS</given-names></name></person-group>
<year>2018</year>
<article-title>Helicobacter pylori infection is associated with an increased risk of Parkinson’s disease: a population-based retrospective cohort
study</article-title>. <source/>Parkinsonism Relat Disord<volume> 47</volume>: <fpage>26</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="pmid">29174171</pub-id></mixed-citation>
</ref>
<ref id="r87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Okubo</surname><given-names>H</given-names></name><name><surname>Miyake</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>W</given-names></name><name><surname>Kiyohara</surname><given-names>C</given-names></name><name><surname>Tsuboi</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Oeda</surname><given-names>T</given-names></name><name><surname>Shimada</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>N</given-names></name><name><surname>Sakae</surname><given-names>N</given-names></name><name><surname>Fukuyama</surname><given-names>H</given-names></name><name><surname>Hirota</surname><given-names>Y</given-names></name><name><surname>Nagai</surname><given-names>M</given-names></name></person-group>, Fukuoka Kinki Parkinson’s Disease Study Group.<year>2012</year>
<article-title>Dietary patterns and risk of Parkinson’s disease: a case-control study in
Japan</article-title>. <source/>Eur J Neurol<volume> 19</volume>: <fpage>681</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="pmid">22136555</pub-id></mixed-citation>
</ref>
<ref id="r88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Fung</surname><given-names>TT</given-names></name><name><surname>Logroscino</surname><given-names>G</given-names></name><name><surname>Schwarzschild</surname><given-names>MA</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name></person-group>
<year>2007</year>
<article-title>Prospective study of dietary pattern and risk of Parkinson disease</article-title>. <source/>Am J Clin Nutr<volume> 86</volume>:
<fpage>1486</fpage>–<lpage>1494</lpage>. <pub-id pub-id-type="pmid">17991663</pub-id></mixed-citation>
</ref>
<ref id="r89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Giacosa</surname><given-names>A</given-names></name><name><surname>Barale</surname><given-names>R</given-names></name><name><surname>Bavaresco</surname><given-names>L</given-names></name><name><surname>Gatenby</surname><given-names>P</given-names></name><name><surname>Gerbi</surname><given-names>V</given-names></name><name><surname>Janssens</surname><given-names>J</given-names></name><name><surname>Johnston</surname><given-names>B</given-names></name><name><surname>Kas</surname><given-names>K</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><name><surname>Mainguet</surname><given-names>P</given-names></name><name><surname>Morazzoni</surname><given-names>P</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>Pelucchi</surname><given-names>C</given-names></name><name><surname>Pezzotti</surname><given-names>M</given-names></name><name><surname>Rondanelli</surname><given-names>M</given-names></name></person-group>
<year>2013</year>
<article-title>Cancer prevention in Europe: the Mediterranean diet as a protective choice</article-title>. <source/>Eur J Cancer Prev<volume>
22</volume>: <fpage>90</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="pmid">22644232</pub-id></mixed-citation>
</ref>
<ref id="r90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Romagnolo</surname><given-names>DF</given-names></name><name><surname>Selmin</surname><given-names>OI</given-names></name></person-group>
<year>2017</year>
<article-title>Mediterranean diet and prevention of chronic diseases</article-title>. <source/>Nutr Today<volume> 52</volume>:
<fpage>208</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="pmid">29051674</pub-id></mixed-citation>
</ref>
<ref id="r91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Aguilera</surname><given-names>Y</given-names></name><name><surname>Martin-Cabrejas</surname><given-names>MA</given-names></name><name><surname>de Mejia</surname><given-names>EG</given-names></name></person-group>
<year>2016</year>
<article-title>Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic
diseases</article-title>. <source/>Phytochem Rev<volume> 15</volume>: <fpage>405</fpage>–<lpage>423</lpage>. </mixed-citation>
</ref>
<ref id="r92">
<label>92</label>
<mixed-citation publication-type="book"><person-group><name><surname>Farooqui</surname><given-names>AA</given-names></name><name><surname>Farooqui</surname><given-names>T</given-names></name></person-group>
<year>2018</year>. Effects of Mediterranean diet components on neurodegenerative diseases. In Role of the Mediterranean diet in the brain and neurodegenerative diseases.
1–16.</mixed-citation>
</ref>
<ref id="r93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Cassani</surname><given-names>E</given-names></name><name><surname>Barichella</surname><given-names>M</given-names></name><name><surname>Ferri</surname><given-names>V</given-names></name><name><surname>Pinelli</surname><given-names>G</given-names></name><name><surname>Iorio</surname><given-names>L</given-names></name><name><surname>Bolliri</surname><given-names>C</given-names></name><name><surname>Caronni</surname><given-names>S</given-names></name><name><surname>Faierman</surname><given-names>SA</given-names></name><name><surname>Mottolese</surname><given-names>A</given-names></name><name><surname>Pusani</surname><given-names>C</given-names></name><name><surname>Monajemi</surname><given-names>F</given-names></name><name><surname>Pasqua</surname><given-names>M</given-names></name><name><surname>Lubisco</surname><given-names>A</given-names></name><name><surname>Cereda</surname><given-names>E</given-names></name><name><surname>Frazzitta</surname><given-names>G</given-names></name><name><surname>Petroni</surname><given-names>ML</given-names></name><name><surname>Pezzoli</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>Dietary habits in Parkinson’s disease: adherence to Mediterranean diet</article-title>. <source/>Parkinsonism Relat Disord<volume>
42</volume>: <fpage>40</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">28647435</pub-id></mixed-citation>
</ref>
<ref id="r94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group><name><surname>De Filippis</surname><given-names>F</given-names></name><name><surname>Pellegrini</surname><given-names>N</given-names></name><name><surname>Vannini</surname><given-names>L</given-names></name><name><surname>Jeffery</surname><given-names>IB</given-names></name><name><surname>La Storia</surname><given-names>A</given-names></name><name><surname>Laghi</surname><given-names>L</given-names></name><name><surname>Serrazanetti</surname><given-names>DI</given-names></name><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>Ferrocino</surname><given-names>I</given-names></name><name><surname>Lazzi</surname><given-names>C</given-names></name><name><surname>Turroni</surname><given-names>S</given-names></name><name><surname>Cocolin</surname><given-names>L</given-names></name><name><surname>Brigidi</surname><given-names>P</given-names></name><name><surname>Neviani</surname><given-names>E</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>O’Toole</surname><given-names>PW</given-names></name><name><surname>Ercolini</surname><given-names>D</given-names></name></person-group>
<year>2016</year>
<article-title>High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome</article-title>.
<source/>Gut<volume> 65</volume>: <fpage>1812</fpage>–<lpage>1821</lpage>. <pub-id pub-id-type="pmid">26416813</pub-id></mixed-citation>
</ref>
<ref id="r95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ley</surname><given-names>RE</given-names></name></person-group>
<year>2016</year>
<article-title>Gut microbiota in 2015: Prevotella in the gut: choose carefully</article-title>. <source/>Nat Rev Gastroenterol Hepatol<volume>
13</volume>: <fpage>69</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="pmid">26828918</pub-id></mixed-citation>
</ref>
<ref id="r96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group><name><surname>De Filippo</surname><given-names>C</given-names></name><name><surname>Cavalieri</surname><given-names>D</given-names></name><name><surname>Di Paola</surname><given-names>M</given-names></name><name><surname>Ramazzotti</surname><given-names>M</given-names></name><name><surname>Poullet</surname><given-names>JB</given-names></name><name><surname>Massart</surname><given-names>S</given-names></name><name><surname>Collini</surname><given-names>S</given-names></name><name><surname>Pieraccini</surname><given-names>G</given-names></name><name><surname>Lionetti</surname><given-names>P</given-names></name></person-group>
<year>2010</year>
<article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title>.
<source/>Proc Natl Acad Sci USA<volume> 107</volume>: <fpage>14691</fpage>–<lpage>14696</lpage>. <pub-id pub-id-type="pmid">20679230</pub-id></mixed-citation>
</ref>
<ref id="r97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Wu</surname><given-names>GD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Bittinger</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>YY</given-names></name><name><surname>Keilbaugh</surname><given-names>SA</given-names></name><name><surname>Bewtra</surname><given-names>M</given-names></name><name><surname>Knights</surname><given-names>D</given-names></name><name><surname>Walters</surname><given-names>WA</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Gilroy</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Baldassano</surname><given-names>R</given-names></name><name><surname>Nessel</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Lewis</surname><given-names>JD</given-names></name></person-group>
<year>2011</year>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>. <source/>Science<volume> 334</volume>:
<fpage>105</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="pmid">21885731</pub-id></mixed-citation>
</ref>
<ref id="r98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Statovci</surname><given-names>D</given-names></name><name><surname>Aguilera</surname><given-names>M</given-names></name><name><surname>MacSharry</surname><given-names>J</given-names></name><name><surname>Melgar</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>The impact of Western diet and nutrients on the microbiota and immune response at mucosal interfaces</article-title>. <source/>Front
Immunol<volume> 8</volume>: <fpage>838</fpage>. <pub-id pub-id-type="pmid">28804483</pub-id></mixed-citation>
</ref>
<ref id="r99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Subar</surname><given-names>AF</given-names></name><name><surname>Hollenbeck</surname><given-names>A</given-names></name><name><surname>Schatzkin</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Dietary fiber intake and mortality in the NIH-AARP diet and health study</article-title>. <source/>Arch Intern Med<volume>
171</volume>: <fpage>1061</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="pmid">21321288</pub-id></mixed-citation>
</ref>
<ref id="r100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Zinöcker</surname><given-names>MK</given-names></name><name><surname>Lindseth</surname><given-names>IA</given-names></name></person-group>
<year>2018</year>
<article-title>The Western diet–microbiome-host interaction and its role in metabolic disease</article-title>. <source/>Nutrients<volume>
10</volume>: <fpage>365</fpage>. </mixed-citation>
</ref>
<ref id="r101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Pendyala</surname><given-names>S</given-names></name><name><surname>Walker</surname><given-names>JM</given-names></name><name><surname>Holt</surname><given-names>PR</given-names></name></person-group>
<year>2012</year>
<article-title>A high-fat diet is associated with endotoxemia that originates from the gut</article-title>. <source/>Gastroenterology<volume>
142</volume>: <fpage>1100</fpage>–<lpage>1101.e2</lpage>. <pub-id pub-id-type="pmid">22326433</pub-id></mixed-citation>
</ref>
<ref id="r102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ghosh</surname><given-names>SS</given-names></name><name><surname>Bie</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group>
<year>2014</year>
<article-title>Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in
LDLR-/- mice—role of intestinal permeability and macrophage activation</article-title>. <source/>PLoS One<volume> 9</volume>: <fpage>e108577</fpage>. <pub-id pub-id-type="pmid">25251395</pub-id></mixed-citation>
</ref>
<ref id="r103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Caroff</surname><given-names>M</given-names></name><name><surname>Karibian</surname><given-names>D</given-names></name></person-group>
<year>2003</year>
<article-title>Structure of bacterial lipopolysaccharides</article-title>. <source/>Carbohydr Res<volume> 338</volume>:
<fpage>2431</fpage>–<lpage>2447</lpage>. <pub-id pub-id-type="pmid">14670707</pub-id></mixed-citation>
</ref>
<ref id="r104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Guerville</surname><given-names>M</given-names></name><name><surname>Leroy</surname><given-names>A</given-names></name><name><surname>Sinquin</surname><given-names>A</given-names></name><name><surname>Laugerette</surname><given-names>F</given-names></name><name><surname>Michalski</surname><given-names>MC</given-names></name><name><surname>Boudry</surname><given-names>G</given-names></name></person-group>
<year>2017</year>
<article-title>Western-diet consumption induces alteration of barrier function mechanisms in the ileum that correlates with metabolic endotoxemia in
rats</article-title>. <source/>Am J Physiol Endocrinol Metab<volume> 313</volume>: <fpage>E107</fpage>–<lpage>E120</lpage>. <pub-id pub-id-type="pmid">28400412</pub-id></mixed-citation>
</ref>
<ref id="r105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Herieka</surname><given-names>M</given-names></name><name><surname>Faraj</surname><given-names>TA</given-names></name><name><surname>Erridge</surname><given-names>C</given-names></name></person-group>
<year>2016</year>
<article-title>Reduced dietary intake of pro-inflammatory Toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy
men</article-title>. <source/>Nutr Metab Cardiovasc Dis<volume> 26</volume>: <fpage>194</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="pmid">26803597</pub-id></mixed-citation>
</ref>
<ref id="r106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name></person-group>
<year>2018</year>
<article-title>Western diet feeding influences gut microbiota profiles in apoE knockout mice</article-title>. <source/>Lipids Health Dis<volume>
17</volume>: <fpage>159</fpage>. <pub-id pub-id-type="pmid">30021609</pub-id></mixed-citation>
</ref>
<ref id="r107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Agus</surname><given-names>A</given-names></name><name><surname>Denizot</surname><given-names>J</given-names></name><name><surname>Thévenot</surname><given-names>J</given-names></name><name><surname>Martinez-Medina</surname><given-names>M</given-names></name><name><surname>Massier</surname><given-names>S</given-names></name><name><surname>Sauvanet</surname><given-names>P</given-names></name><name><surname>Bernalier-Donadille</surname><given-names>A</given-names></name><name><surname>Denis</surname><given-names>S</given-names></name><name><surname>Hofman</surname><given-names>P</given-names></name><name><surname>Bonnet</surname><given-names>R</given-names></name><name><surname>Billard</surname><given-names>E</given-names></name><name><surname>Barnich</surname><given-names>N</given-names></name></person-group>
<year>2016</year>
<article-title>Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive <italic>E. coli</italic> infection and
intestinal inflammation</article-title>. <source/>Sci Rep<volume> 6</volume>: <fpage>19032</fpage>. <pub-id pub-id-type="pmid">26742586</pub-id></mixed-citation>
</ref>
<ref id="r108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Poppleton</surname><given-names>DI</given-names></name><name><surname>Duchateau</surname><given-names>M</given-names></name><name><surname>Hourdel</surname><given-names>V</given-names></name><name><surname>Matondo</surname><given-names>M</given-names></name><name><surname>Flechsler</surname><given-names>J</given-names></name><name><surname>Klingl</surname><given-names>A</given-names></name><name><surname>Beloin</surname><given-names>C</given-names></name><name><surname>Gribaldo</surname><given-names>S</given-names></name></person-group>
<year>2017</year>
<article-title>Outer membrane proteome of <italic>Veillonella parvula</italic>: a diderm firmicute of the human microbiome</article-title>. <source/>Front
Microbiol<volume> 8</volume>: <fpage>1215</fpage>. <pub-id pub-id-type="pmid">28713344</pub-id></mixed-citation>
</ref>
<ref id="r109">
<label>109</label>
<mixed-citation publication-type="book"><person-group><name><surname>Metchnikoff</surname><given-names>II</given-names></name></person-group>
<year>2004</year>. The prolongation of life: optimistic studies. Springer Publishing Company, New York.</mixed-citation>
</ref>
<ref id="r110">
<label>110</label>
<mixed-citation publication-type="book"><person-group><name><surname>Boaventura</surname><given-names>C</given-names></name><name><surname>Azevedo</surname><given-names>R</given-names></name><name><surname>Uetanabaro</surname><given-names>A</given-names></name><name><surname>Nicoli</surname><given-names>J</given-names></name><name><surname>Braga</surname><given-names>LG</given-names></name></person-group>
<year>2012</year>. The benefits of probiotics in human and animal nutrition. In New Advances in the Basic and Clinical Gastroenterology.</mixed-citation>
</ref>
<ref id="r111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>Merenstein</surname><given-names>DJ</given-names></name><name><surname>Pot</surname><given-names>B</given-names></name><name><surname>Morelli</surname><given-names>L</given-names></name><name><surname>Canani</surname><given-names>RB</given-names></name><name><surname>Flint</surname><given-names>HJ</given-names></name><name><surname>Salminen</surname><given-names>S</given-names></name><name><surname>Calder</surname><given-names>PC</given-names></name><name><surname>Sanders</surname><given-names>ME</given-names></name></person-group>
<year>2014</year>
<article-title>Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and
appropriate use of the term probiotic</article-title>. <source/>Nat Rev Gastroenterol Hepatol<volume> 11</volume>: <fpage>506</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="pmid">24912386</pub-id></mixed-citation>
</ref>
<ref id="r112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Varankovich</surname><given-names>NV</given-names></name><name><surname>Nickerson</surname><given-names>MT</given-names></name><name><surname>Korber</surname><given-names>DR</given-names></name></person-group>
<year>2015</year>
<article-title>Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases</article-title>. <source/>Front
Microbiol<volume> 6</volume>: <fpage>685</fpage>. <pub-id pub-id-type="pmid">26236287</pub-id></mixed-citation>
</ref>
<ref id="r113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Khalif</surname><given-names>IL</given-names></name><name><surname>Quigley</surname><given-names>EMM</given-names></name><name><surname>Konovitch</surname><given-names>EA</given-names></name><name><surname>Maximova</surname><given-names>ID</given-names></name></person-group>
<year>2005</year>
<article-title>Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation</article-title>.
<source/>Dig Liver Dis<volume> 37</volume>: <fpage>838</fpage>–<lpage>849</lpage>. <pub-id pub-id-type="pmid">16169298</pub-id></mixed-citation>
</ref>
<ref id="r114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Alkhouri</surname><given-names>R</given-names></name><name><surname>Baker</surname><given-names>RD</given-names></name><name><surname>Bard</surname><given-names>JE</given-names></name><name><surname>Quigley</surname><given-names>EM</given-names></name><name><surname>Baker</surname><given-names>SS</given-names></name></person-group>
<year>2014</year>
<article-title>Structural changes in the gut microbiome of constipated patients</article-title>. <source/>Physiol Genomics<volume> 46</volume>:
<fpage>679</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="pmid">25073603</pub-id></mixed-citation>
</ref>
<ref id="r115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Dimidi</surname><given-names>E</given-names></name><name><surname>Christodoulides</surname><given-names>S</given-names></name><name><surname>Fragkos</surname><given-names>KC</given-names></name><name><surname>Scott</surname><given-names>SM</given-names></name><name><surname>Whelan</surname><given-names>K</given-names></name></person-group>
<year>2014</year>
<article-title>The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled
trials</article-title>. <source/>Am J Clin Nutr<volume> 100</volume>: <fpage>1075</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="pmid">25099542</pub-id></mixed-citation>
</ref>
<ref id="r116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Cassani</surname><given-names>E</given-names></name><name><surname>Privitera</surname><given-names>G</given-names></name><name><surname>Pezzoli</surname><given-names>G</given-names></name><name><surname>Pusani</surname><given-names>C</given-names></name><name><surname>Madio</surname><given-names>C</given-names></name><name><surname>Iorio</surname><given-names>L</given-names></name><name><surname>Barichella</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Use of probiotics for the treatment of constipation in Parkinson’s disease patients</article-title>. <source/>Minerva Gastroenterol
Dietol<volume> 57</volume>: <fpage>117</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="pmid">21587143</pub-id></mixed-citation>
</ref>
<ref id="r117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Parashar</surname><given-names>A</given-names></name><name><surname>Udayabanu</surname><given-names>M</given-names></name></person-group>
<year>2017</year>
<article-title>Gut microbiota: implications in Parkinson’s disease</article-title>. <source/>Parkinsonism Relat Disord<volume> 38</volume>:
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="pmid">28202372</pub-id></mixed-citation>
</ref>
<ref id="r118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Akkasheh</surname><given-names>G</given-names></name><name><surname>Kashani-Poor</surname><given-names>Z</given-names></name><name><surname>Tajabadi-Ebrahimi</surname><given-names>M</given-names></name><name><surname>Jafari</surname><given-names>P</given-names></name><name><surname>Akbari</surname><given-names>H</given-names></name><name><surname>Taghizadeh</surname><given-names>M</given-names></name><name><surname>Memarzadeh</surname><given-names>MR</given-names></name><name><surname>Asemi</surname><given-names>Z</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind,
placebo-controlled trial</article-title>. <source/>Nutrition<volume> 32</volume>: <fpage>315</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="pmid">26706022</pub-id></mixed-citation>
</ref>
<ref id="r119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Desbonnet</surname><given-names>L</given-names></name><name><surname>Garrett</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Bienenstock</surname><given-names>J</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<year>2008</year>
<article-title>The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat</article-title>. <source/>J Psychiatr
Res<volume> 43</volume>: <fpage>164</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="pmid">18456279</pub-id></mixed-citation>
</ref>
<ref id="r120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Akbari</surname><given-names>E</given-names></name><name><surname>Asemi</surname><given-names>Z</given-names></name><name><surname>Daneshvar Kakhaki</surname><given-names>R</given-names></name><name><surname>Bahmani</surname><given-names>F</given-names></name><name><surname>Kouchaki</surname><given-names>E</given-names></name><name><surname>Tamtaji</surname><given-names>OR</given-names></name><name><surname>Hamidi</surname><given-names>GA</given-names></name><name><surname>Salami</surname><given-names>M</given-names></name></person-group>
<year>2016</year>
<article-title>Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and
controlled trial</article-title>. <source/>Front Aging Neurosci<volume> 8</volume>: <fpage>256</fpage>. <pub-id pub-id-type="pmid">27891089</pub-id></mixed-citation>
</ref>
<ref id="r121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Borzabadi</surname><given-names>S</given-names></name><name><surname>Oryan</surname><given-names>S</given-names></name><name><surname>Eidi</surname><given-names>A</given-names></name><name><surname>Aghadavod</surname><given-names>E</given-names></name><name><surname>Daneshvar Kakhaki</surname><given-names>R</given-names></name><name><surname>Tamtaji</surname><given-names>OR</given-names></name><name><surname>Taghizadeh</surname><given-names>M</given-names></name><name><surname>Asemi</surname><given-names>Z</given-names></name></person-group>
<year>2018</year>
<article-title>The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s
disease: a randomized, double-blind, placebo controlled trial</article-title>. <source/>Arch Iran Med<volume> 21</volume>: <fpage>289</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="pmid">30041526</pub-id></mixed-citation>
</ref>
<ref id="r122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Tamtaji</surname><given-names>OR</given-names></name><name><surname>Taghizadeh</surname><given-names>M</given-names></name><name><surname>Daneshvar Kakhaki</surname><given-names>R</given-names></name><name><surname>Kouchaki</surname><given-names>E</given-names></name><name><surname>Bahmani</surname><given-names>F</given-names></name><name><surname>Borzabadi</surname><given-names>S</given-names></name><name><surname>Oryan</surname><given-names>S</given-names></name><name><surname>Mafi</surname><given-names>A</given-names></name><name><surname>Asemi</surname><given-names>Z</given-names></name></person-group>
<year>2019</year>
<article-title>Clinical and metabolic response to probiotic administration in people with Parkinson’s disease: a randomized, double-blind,
placebo-controlled trial</article-title>. <source/>Clin Nutr<volume> 38</volume>: <fpage>1031</fpage>–<lpage>1035</lpage>. <pub-id pub-id-type="pmid">29891223</pub-id></mixed-citation>
</ref>
<ref id="r123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Guarner</surname><given-names>F</given-names></name><name><surname>Khan</surname><given-names>AG</given-names></name><name><surname>Garisch</surname><given-names>J</given-names></name><name><surname>Eliakim</surname><given-names>R</given-names></name><name><surname>Gangl</surname><given-names>A</given-names></name><name><surname>Thomson</surname><given-names>A</given-names></name><name><surname>Krabshuis</surname><given-names>J</given-names></name><name><surname>Lemair</surname><given-names>T</given-names></name><name><surname>Kaufmann</surname><given-names>P</given-names></name><name><surname>de Paula</surname><given-names>JA</given-names></name><name><surname>Fedorak</surname><given-names>R</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><name><surname>Sanders</surname><given-names>ME</given-names></name><name><surname>Szajewska</surname><given-names>H</given-names></name><name><surname>Ramakrishna</surname><given-names>BS</given-names></name><name><surname>Karakan</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name></person-group>, World Gastroenterology Organization.<year>2012</year>
<article-title>World gastroenterology organisation global guidelines: probiotics and prebiotics october
2011</article-title>. <source/>J Clin Gastroenterol<volume> 46</volume>: <fpage>468</fpage>–<lpage>481</lpage>. <pub-id pub-id-type="pmid">22688142</pub-id></mixed-citation>
</ref>
<ref id="r124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Kuo</surname><given-names>SM</given-names></name></person-group>
<year>2013</year>
<article-title>The interplay between fiber and the intestinal microbiome in the inflammatory response</article-title>. <source/>Adv Nutr<volume>
4</volume>: <fpage>16</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="pmid">23319119</pub-id></mixed-citation>
</ref>
<ref id="r125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Pandey</surname><given-names>KR</given-names></name><name><surname>Naik</surname><given-names>SR</given-names></name><name><surname>Vakil</surname><given-names>BV</given-names></name></person-group>
<year>2015</year>
<article-title>Probiotics, prebiotics and synbiotics—a review</article-title>. <source/>J Food Sci Technol<volume> 52</volume>:
<fpage>7577</fpage>–<lpage>7587</lpage>. <pub-id pub-id-type="pmid">26604335</pub-id></mixed-citation>
</ref>
<ref id="r126">
<label>126</label>
<mixed-citation publication-type="book"><person-group><name><surname>Kovács</surname><given-names>Z</given-names></name><name><surname>Benjamins</surname><given-names>E</given-names></name><name><surname>Grau</surname><given-names>K</given-names></name><name><surname>Rehman</surname><given-names>AU</given-names></name><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Czermak</surname><given-names>P</given-names></name></person-group>
<year>2013</year> Recent developments in manufacturing oligosaccharides with prebiotic functions. <italic>In</italic> Biotechnology of food and feed additives. Springer,
Berlin, Heidelberg, pp. 257–295. </mixed-citation>
</ref>
<ref id="r127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Conlon</surname><given-names>MA</given-names></name><name><surname>Bird</surname><given-names>AR</given-names></name></person-group>
<year>2014</year>
<article-title>The impact of diet and lifestyle on gut microbiota and human health</article-title>. <source/>Nutrients<volume> 7</volume>:
<fpage>17</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="pmid">25545101</pub-id></mixed-citation>
</ref>
<ref id="r128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Markowiak</surname><given-names>P</given-names></name><name><surname>Śliżewska</surname><given-names>K</given-names></name></person-group>
<year>2017</year>
<article-title>Effects of probiotics, prebiotics, and synbiotics on human health</article-title>. <source/>Nutrients<volume> 9</volume>:
<fpage>1021</fpage>. </mixed-citation>
</ref>
<ref id="r129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Slavin</surname><given-names>J</given-names></name></person-group>
<year>2013</year>
<article-title>Fiber and prebiotics: mechanisms and health benefits</article-title>. <source/>Nutrients<volume> 5</volume>:
<fpage>1417</fpage>–<lpage>1435</lpage>. <pub-id pub-id-type="pmid">23609775</pub-id></mixed-citation>
</ref>
<ref id="r130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Quigley</surname><given-names>EMM</given-names></name></person-group>
<year>2011</year>
<article-title>The enteric microbiota in the pathogenesis and management of constipation</article-title>. <source/>Best Pract Res Clin
Gastroenterol<volume> 25</volume>: <fpage>119</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="pmid">21382583</pub-id></mixed-citation>
</ref>
<ref id="r131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Erny</surname><given-names>D</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>AL</given-names></name><name><surname>Jaitin</surname><given-names>D</given-names></name><name><surname>Wieghofer</surname><given-names>P</given-names></name><name><surname>Staszewski</surname><given-names>O</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Keren-Shaul</surname><given-names>H</given-names></name><name><surname>Mahlakoiv</surname><given-names>T</given-names></name><name><surname>Jakobshagen</surname><given-names>K</given-names></name><name><surname>Buch</surname><given-names>T</given-names></name><name><surname>Schwierzeck</surname><given-names>V</given-names></name><name><surname>Utermöhlen</surname><given-names>O</given-names></name><name><surname>Chun</surname><given-names>E</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name><name><surname>McCoy</surname><given-names>KD</given-names></name><name><surname>Diefenbach</surname><given-names>A</given-names></name><name><surname>Staeheli</surname><given-names>P</given-names></name><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name></person-group>
<year>2015</year>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat Neurosci<volume>
18</volume>: <fpage>965</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="r132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Stilling</surname><given-names>RM</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<year>2014</year>
<article-title>Microbial genes, brain &amp; behaviour—epigenetic regulation of the gut-brain axis</article-title>. <source/>Genes Brain
Behav<volume> 13</volume>: <fpage>69</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="pmid">24286462</pub-id></mixed-citation>
</ref>
<ref id="r133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Savignac</surname><given-names>HM</given-names></name><name><surname>Corona</surname><given-names>G</given-names></name><name><surname>Mills</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Spencer</surname><given-names>JP</given-names></name><name><surname>Tzortzis</surname><given-names>G</given-names></name><name><surname>Burnet</surname><given-names>PW</given-names></name></person-group>
<year>2013</year>
<article-title>Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine</article-title>.
<source/>Neurochem Int<volume> 63</volume>: <fpage>756</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="pmid">24140431</pub-id></mixed-citation>
</ref>
<ref id="r134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Cencic</surname><given-names>A</given-names></name><name><surname>Chingwaru</surname><given-names>W</given-names></name></person-group>
<year>2010</year>
<article-title>The role of functional foods, nutraceuticals, and food supplements in intestinal health</article-title>. <source/>Nutrients<volume>
2</volume>: <fpage>611</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="pmid">22254045</pub-id></mixed-citation>
</ref>
<ref id="r135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group><name><surname>McFarlane</surname><given-names>C</given-names></name><name><surname>Ramos</surname><given-names>CI</given-names></name><name><surname>Johnson</surname><given-names>DW</given-names></name><name><surname>Campbell</surname><given-names>KL</given-names></name></person-group>
<year>2019</year>
<article-title>Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis</article-title>.
<source/>J Ren Nutr<volume> 29</volume>: <fpage>209</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="pmid">30366767</pub-id></mixed-citation>
</ref>
<ref id="r136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Sáez-Lara</surname><given-names>MJ</given-names></name><name><surname>Robles-Sanchez</surname><given-names>C</given-names></name><name><surname>Ruiz-Ojeda</surname><given-names>FJ</given-names></name><name><surname>Plaza-Diaz</surname><given-names>J</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name></person-group>
<year>2016</year>
<article-title>Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a
review of human clinical trials</article-title>. <source/>Int J Mol Sci<volume> 17</volume>: <fpage>928</fpage>. </mixed-citation>
</ref>
<ref id="r137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Ding</surname><given-names>C</given-names></name><name><surname>Ge</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>N</given-names></name></person-group>
<year>2016</year>
<article-title>Efficacy of synbiotics in patients with slow transit constipation: a prospective randomized trial</article-title>.
<source/>Nutrients<volume> 8</volume>: <fpage>605</fpage>. </mixed-citation>
</ref>
<ref id="r138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Barichella</surname><given-names>M</given-names></name><name><surname>Pacchetti</surname><given-names>C</given-names></name><name><surname>Bolliri</surname><given-names>C</given-names></name><name><surname>Cassani</surname><given-names>E</given-names></name><name><surname>Iorio</surname><given-names>L</given-names></name><name><surname>Pusani</surname><given-names>C</given-names></name><name><surname>Pinelli</surname><given-names>G</given-names></name><name><surname>Privitera</surname><given-names>G</given-names></name><name><surname>Cesari</surname><given-names>I</given-names></name><name><surname>Faierman</surname><given-names>SA</given-names></name><name><surname>Caccialanza</surname><given-names>R</given-names></name><name><surname>Pezzoli</surname><given-names>G</given-names></name><name><surname>Cereda</surname><given-names>E</given-names></name></person-group>
<year>2016</year>
<article-title>Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT</article-title>.
<source/>Neurology<volume> 87</volume>: <fpage>1274</fpage>–<lpage>1280</lpage>. <pub-id pub-id-type="pmid">27543643</pub-id></mixed-citation>
</ref>
<ref id="r139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Asemi</surname><given-names>Z</given-names></name><name><surname>Zare</surname><given-names>Z</given-names></name><name><surname>Shakeri</surname><given-names>H</given-names></name><name><surname>Sabihi</surname><given-names>SS</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2
diabetes</article-title>. <source/>Ann Nutr Metab<volume> 63</volume>: <fpage>1</fpage>–<lpage>9</lpage>. </mixed-citation>
</ref>
<ref id="r140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Moroti</surname><given-names>C</given-names></name><name><surname>Souza Magri</surname><given-names>LF</given-names></name><name><surname>de Rezende Costa</surname><given-names>M</given-names></name><name><surname>Cavallini</surname><given-names>DC</given-names></name><name><surname>Sivieri</surname><given-names>K</given-names></name></person-group>
<year>2012</year>
<article-title>Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes
mellitus</article-title>. <source/>Lipids Health Dis<volume> 11</volume>: <fpage>29</fpage>. <pub-id pub-id-type="pmid">22356933</pub-id></mixed-citation>
</ref>
<ref id="r141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group><name><surname>van der Aa</surname><given-names>LB</given-names></name><name><surname>Heymans</surname><given-names>HS</given-names></name><name><surname>van Aalderen</surname><given-names>WM</given-names></name><name><surname>Sillevis Smitt</surname><given-names>JH</given-names></name><name><surname>Knol</surname><given-names>J</given-names></name><name><surname>Ben Amor</surname><given-names>K</given-names></name><name><surname>Goossens</surname><given-names>DA</given-names></name><name><surname>Sprikkelman</surname><given-names>AB</given-names></name></person-group>, Synbad Study Group.<year>2010</year>
<article-title>Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial</article-title>.
<source/>Clin Exp Allergy<volume> 40</volume>: <fpage>795</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="pmid">20184604</pub-id></mixed-citation>
</ref>
<ref id="r142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group><name><surname>Kekkonen</surname><given-names>RA</given-names></name><name><surname>Holma</surname><given-names>R</given-names></name><name><surname>Hatakka</surname><given-names>K</given-names></name><name><surname>Suomalainen</surname><given-names>T</given-names></name><name><surname>Poussa</surname><given-names>T</given-names></name><name><surname>Adlercreutz</surname><given-names>H</given-names></name><name><surname>Korpela</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>A probiotic mixture including galactooligosaccharides decreases fecal β-glucosidase activity but does not affect serum enterolactone
concentration in men during a two-week intervention</article-title>. <source/>J Nutr<volume> 141</volume>: <fpage>870</fpage>–<lpage>876</lpage>. <pub-id pub-id-type="pmid">21411613</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>